<SEC-DOCUMENT>0001437749-12-003884.txt : 20120416
<SEC-HEADER>0001437749-12-003884.hdr.sgml : 20120416
<ACCEPTANCE-DATETIME>20120416084902
ACCESSION NUMBER:		0001437749-12-003884
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20120416
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20120416
DATE AS OF CHANGE:		20120416

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		12759948

	BUSINESS ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719
		BUSINESS PHONE:		6516870414

	MAIL ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>biokey_8k-041612v2.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>
<head>
    <title>biokey_8k-041612v2.htm</title>
    <!--Licensed to: RDG Filings-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">UNITED STATES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt">Washington, D.C. 20549</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">FORM 8-K</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">CURRENT REPORT</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date of Report (Date of earliest event reported): April 16, 2012</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="3" valign="top" width="100%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 18pt; FONT-WEIGHT: bold">BIO-key International, Inc.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Exact name of registrant as specified in its charter)</font></div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="100%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 18pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="top" width="33%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Delaware</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(State or other jurisdiction of incorporation)</font></div>
</td>
<td valign="top" width="34%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1-13463</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Commission File Number)</font></div>
</td>
<td valign="top" width="33%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">41-1741861</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(I.R.S. Employer Identification No.)</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="3" valign="top" width="80%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">3349 Highway 138, Building D, Suite B</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Wall, NJ 07719</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Address of principal executive offices)</font></div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="80%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td colspan="3" valign="top" width="80%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(732)&#160;359-1100</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Registrant&#8217;s telephone number, including area code)</font></div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="80%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="80%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<font style="FONT-STYLE: italic; DISPLAY: inline">see</font> General Instruction A.2 below):</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-WEIGHT: normal">o</font></font></font></font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></font></font></div>
</td>
</tr></table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-WEIGHT: normal">o</font></font></font></font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></font></font></div>
</td>
</tr></table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td align="right" style="WIDTH: 18pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-WEIGHT: normal">o</font></font></font></font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></font></font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td align="right" style="WIDTH: 18pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-WEIGHT: normal">o</font></font></font></font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))</font></font></font></div>
</td>
</tr></table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td align="right" style="WIDTH: 81pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 2.02.&#160;</font></div>
</td>
<td align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Results of Operations and Financial Condition.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 16, 2012, BIO-key International, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for its fourth quarter, year ended December 31, 2011 and preliminary first quarter 2012 results which is included as an exhibit to a Current Report on Form 8-K.&#160;A copy of the press release issued by the Company on April 16, 2012 is attached as Exhibit&#160;99.</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 81pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 9.01.&#160;</font></div>
</td>
<td align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Financial Statements, Pro Forma Financial Information and Exhibit.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td align="right" style="WIDTH: 45pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(d)&#160;</font></div>
</td>
<td align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Exhibits</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td align="right" style="WIDTH: 45pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">99.1&#160;</font></font></div>
</td>
<td align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Press Release, dated April 16, 2012, issued by </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">the Company.</font></font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="38%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">BIO-KEY INTERNATIONAL, INC.</font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date: April 16, 2012</font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By: </font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;Cecilia C. Welch</font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="bottom" width="35%">
<div>Cecilia C. Welch</div>

<div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer</font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%">&#160;</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%">&#160;</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT INDEX</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 99pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit No.</font></font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Description</font></font></div>
</td>
</tr></table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 99pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">99.1</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Press Release, dated <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">April 16, 2012, issued by </font>the Company.</font></div>
</td>
</tr></table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font><br>
&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">4</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
<head>
    <title>ex99-1.htm</title>
    <!--Licensed to: rdg filings-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">Exhibit 99.1</font></div>

<div style="TEXT-ALIGN: right">&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="59%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><img src="logo.jpg" alt=""></font></td>
<td colspan="2" valign="bottom" width="8%">
<div><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 24pt; FONT-WEIGHT: bold">NEWS RELEASE </font></font></div>

<div>&#160;</div>
</td>
</tr><tr>
<td width="59%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="8%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contacts:</font></td>
<td valign="top" width="33%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">BIO-key International, Inc.</font></font> </font>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Scott Mahnken</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">732-359-1113</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: center"><br>
<font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">BIO-key&#174; International, Inc. Reports</font></div>
</div>

<div>
<div align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">Q4 2011 and Preliminary First Quarter 2012 Financial Results</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Wall, NJ, April 16, 2012</font> &#8211; BIO-key International, Inc. (OTCBB: BKYI.OB), a global leader in fingerprint biometric identification solutions and advanced mobile identification technology, today reported financial results for the full year and fourth quarter ended December 31, 2011 and preliminary first quarter 2012 results.&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Total revenue for the three months ended December 31, 2011 was approximately $545,000, representing a decrease of 3% from the $565,000 reported for the quarter ended December 31, 2010. There was an increase in the service revenues related to custom software and for maintenance and support contracts, which was driven by a mix of new accounts and renewed maintenance agreements from existing customers. The increase was offset by a decrease of core license revenue.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">BIO-key&#8217;s gross margin for the fourth quarter of 2011 was 65% compared to 75% for the same period in 2010, due to costs associated with the custom software revenue. Operating expenses for the fourth quarter of 2011 increased 44%, primarily attributable to the increase of our reserve for doubtful accounts of $386,000 due to a contract whose payments are behind schedule, to approximately $1,324,000 compared to $921,000 in the comparable quarter ended December 31, 2010.&#160;Operating loss for the fourth quarter of<font style="DISPLAY: inline; FONT-SIZE: 12pt">&#160;</font>2011 was ($970,590), compared to operating loss of ($495,078) reported in the quarter ended December 31, 2010.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net loss for the three months ended December 31, 2011 was ($1,003,286) compared to net loss of ($598,322) for the comparable period in 2010.&#160;&#160;Net<font style="DISPLAY: inline; FONT-SIZE: 12pt">&#160;</font>loss for the 2010 period included approximately $88,000 in income related to derivative and fair value adjustments that were no longer relevant in 2011.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Our business performance year-over-year was basically flat; however late in the fourth quarter, we saw an increase in the adoption rate of our technology, which is reflected in our first quarter 2012 preliminary results,&#8221; stated Mike DePasquale, BIO-key&#8217;s CEO.&#160;&#160;&#160;Large technology companies such as IBM and AT&amp;T have publicly stated that passwords no longer meet today&#8217;s security requirements and that biometrics will replace them for authentication and secure access to important information.&#160;&#160;&#8220;Our partners are starting to sell biometric technology as part of their standard product offering and our secure, convenient fingerprint option is being selected more frequently than ever before.&#160;&#160;By refining our sales strategy and increasing our sales headcount in the first quarter of 2012, we are well-positioned to support our partners in selling BIO-key fingerprint technology in greater volumes which we believe will lead to more consistent&#160;&#160;revenue growth&#160;&#160;and profitability going forward,&#8221; said DePasquale.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">According to market research conducted by RNCOS, the biometric industry is forecasted to grow at a rate of 21% through 2014.&#160;&#160;Today, the majority of the opportunities for biometric technology are within the healthcare industry and government agencies.&#160;&#160;</font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font>&#8220;There&#8217;s a noticeable shift in awareness<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">.&#160;&#160;</font>This is driven by a need for stronger security, compliance and convenience,&#8221; said Scott Mahnken VP Marketing.&#160;&#160;&#8220;We&#8217;re seeing an increase in inquiries and our outbound contact team is seeing increasing acceptance when introducing the technology,&#8221; added Mahnken</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Fiscal Year Comparisons</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Total revenue for the fiscal year ended December 30, 2011 was $3.5 million representing less than 1% decrease from the $3.5 million reported for the same period in 2010.&#160;&#160;Although the revenue amounts are similar, the product mix varied with an increase in third party hardware revenue to approximately $926,000, license revenue of $1.6 million and service revenue of $848,000 for the fiscal year ended December, 2011, compared with third party hardware revenue of approximately $569,000, license revenue of $2.4 million and service revenue of $440,000 for the same period in 2010.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Gross margin for the fiscal year ended December 31, 2011 was approximately $2.7 million, representing a 9% decrease from the same period in 2010 of approximately $3.0 million. Operating expenses for 2011 remained flat to approximately $4,153,000 compared to $4,161,000 in the comparable period ended December 31, 2010.&#160;The decline in operating expenses were primarily related to lower legal, accounting and referral fee expenses, offset by an increase in R&amp;D expenses and reserve for doubtful accounts. Operating loss for the fiscal year ended December 31, 2011 was approximately ($1,455.000) compared to an operating loss of ($1,200,000) reported for the same period in 2010.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net loss for the fiscal year of 2011 was approximately ($1,898,000) compared to net loss of ($307,000) for the comparable period in 2010.&#160;&#160;Net loss for the 2010 period included approximately $1,020,000 in income related to derivative and fair value adjustments and $343,000 in income from discontinued operations, both no longer applicable in 2011.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Liquidity and Capital Resources</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Consolidated cash, cash equivalents and accounts receivables totaled over $630,000 on December 31, 2011, compared to $1.4 million as of December 31, 2010.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Highlights for FY 2011 included the following:&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Purchase Orders for continued product roll-outs at the Cleveland Clinic, Genesis Health Systems, Dayton Children&#8217;s Hospital, Robinson Memorial Hospital, McKesson, Allscripts, MedFlow and LexisNexis.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Initial delivery of a multi-million dollar contract to utilize BIO-key&#8217;s software for a large scale identity project which includes fingerprinting and registering the entire population of mobility users in an as-yet unnamed foreign country.&#160;&#160;The majority of the project is expected to be delivered in the first half of 2012.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Nationwide Children&#8217;s Hospital, one of the largest pediatric hospitals and research institutes in the U.S. implemented Phase 2 of the installation of BIO-key software; expanding the footprint from 300 to 2,500 finger print readers and expanding from 1650 to 6500 users.&#160;&#160;Part of the expansion includes future deployment at Nationwide Children&#8217;s new state of the art facility.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dayton Children's has a staff of over 350 physicians and 1,300 employees and volunteers.&#160;&#160;During Q2 Dayton Children&#8217;s in Ohio contracted with BIO-key to deploy strong identification and authentication for their staff members to comply with Ohio Board of Pharmacy Positive ID requirements inside their Epic deployment.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Announced an agreement with Robinson Memorial Hospital to include our biometric software along with Allscripts Sunrise Clinical Manager.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Launched a new program with OEM partner Softex to integrate BIO-key&#8217;s algorithm within Softex software to provide fingerprint sign on and authentication for 10,000 retail employees of a major wireless telecommunications company.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Signed two new customers through Davisco, a real-time data collection and reporting company for workplace management functionality, servicing Fortune 500 companies and large government agencies.&#160;</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Executed an OEM agreement with Oracle to include BIO-key software as the exclusive biometric solution in the release of Oracle&#8217;s new UAM product.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">First Quarter 2012 Preliminary Results</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">BIO-key&#8217;s preliminary revenue results for the first quarter of 2012 are currently expected to be in the range of $1.3 million to $1.4 million, and the Company is projecting to be profitable.&#160;&#160;These first quarter results are preliminary and subject to completion and review of BIO-key&#8217;s 2012 first quarter financial statements in conjunction with the company&#8217;s 2012 first quarter Form 10-Q filing.&#160;&#160;BIO-key currently plans to announce final results for the first quarter on or before May 16,<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font>2012.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Highlights for the first quarter 2012 included the following:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Awarded a contract to provide fingerprint&#160;&#160;technology for the Provincial Government of British Columbia Department of Corrections.&#160;&#160;The solution will be utilized by inmates and staff to access and track various applications including inmate records and personal services.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Secured agreement to provide biometric technology to a large blood center servicing over 1 million donors.&#160;&#160;BIO-key now&#160;&#160;supports&#160;&#160;four of the largest independent blood centers in US with our TruDonor&#160;&#160;ID solution</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Attended the IBM Pulse Event March 4-7<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font> 2012.&#160;&#160;Pulse&#160;&#160;is the largest annual gathering of IBM resellers in the United States</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Attended HIMSS Conference Feb 20-24<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font> 2012.&#160;&#160;The Health Information Management Systems Society is dedicated to promoting a better understanding of health information systems technology.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Conference Call Details</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">BIO-key has scheduled a call for Monday, April 16<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font>, at 10:00 a.m. Eastern Time to discuss 2011 fourth quarter results and preliminary first quarter 2012 results.&#160; To access the conference call live, dial 800-860-2442 (U.S.) or 412-858-4600 (International) and ask for the BIO-key call at least 10 minutes prior to the start time.&#160; The conference call will also be broadcast live over the Internet by logging onto <font style="DISPLAY: inline; FONT-WEIGHT: bold">www.bio-key.com</font>. A telephonic replay of the conference call will be available through May 16, 2012 and may be accessed by dialing 877-344-7529 (U.S.) 412-317-0088&#160;(International) and using the pass code 10012270#. A streaming audio replay of the webcast will be available shortly after the call on the Company&#8217;s website (www.bio-key.com) for a period of thirty days.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About BIO-key</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers.&#160;BIO-key&#8217;s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world&#8217;s largest identification deployments to improve security, guarantee identity, and help reduce identity theft.&#160;&#160;BIO-key&#8217;s technology is offered directly or by market leading partners around the world. (<font style="DISPLAY: inline; FONT-WEIGHT: bold">http://www.bio-key.com</font>)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">BIO-key Safe Harbor Statement</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certain statements contained in this press release may be construed as &#8220;forward-looking statements&#8221; as defined in the Private Securities Litigation Reform Act of 1995 (the &#8220;Act&#8221;).&#160; The words &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intends,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;believes&#8221; and similar expressions are intended to identify forward-looking statements.&#160; Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the &#8220;safe-harbor&#8221; provisions of the Act.&#160; These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements.&#160; These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel.&#160; For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2011 and its other filings with the Securities and Exchange Commission.&#160; Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.&#160; The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`@$`;@!N``#_X1Q@17AI9@``34T`*@````@`!P$2``,`
M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q
M``(````<````<@$R``(````4````CH=I``0````!````I````-``$,C@```G
M$``0R.```"<0061O8F4@4&AO=&]S:&]P($-3-"!7:6YD;W=S`#(P,3(Z,#0Z
M,3,@,3$Z,S`Z,#8``````Z`!``,````!``$``*`"``0````!````K:`#``0`
M```!````@``````````&`0,``P````$`!@```1H`!0````$```$>`1L`!0``
M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$``!LJ````
M`````$@````!````2`````'_V/_@`!!*1DE&``$"``!(`$@``/_M``Q!9&]B
M95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,
M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`=@"@`P$B``(1`0,1`?_=``0`
M"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$`
M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%
M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D
M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B
M$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D
M154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=7
M9W>'EZ>WQ__:``P#`0`"$0,1`#\`]422224I),2`).@&I*X[K_\`C%P\0NQ^
MCL;FWMT.0XG[.T_R2SWY7_6OT7_#ILIQB+D:9,6')EEPXXF1_`?WB]B][6-+
MWD-:T2YQ,`#S)6#G_7KZLX+BPY8R+!^9C`V_]-GZ+_P1>8]4ZSU7JSR_J.4^
MYO(JG94W^K0S;7_:=[T_2NA]6ZL8Z=BOMKF#<1LI$<_IG[6?V6*N>9)-0C;I
M0^%PA'BSY*']7TQ_QYO99/\`C3H']#Z;;8/&ZQM7_18+U1?_`(S^L$G9A8S1
MV#G6./X;$?I_^*^YT.ZGG!@[U8K9/_;]X_\`==;>-_BZ^J]+0+:;<HC\ZZU_
M_4TFFO\`Z"(',2W(B@S^&X]!`Y/+B/\`TI0><_\`'.ZWWP\7[[`K./\`XTKQ
M`RNF!P[OIM_)7;7_`.C%T[/J;]5F"&],H/\`6;N_ZO<HV_4GZJVSNZ;4)_<W
M,_\`/3F)PAG'Z88SGY`[X)#R/_H;1P_\9'U<R"&Y!NPG'3]-7+?^W*#:U='B
M9V'FU"[#OKR*C^?4X.'P.U<UD_XM?J];K0[(Q3V%=F]OS&2V[_JEA9'^+SZP
M=,M^U=%S!;8WC8XXUQ_D_2=19_URRM'BRQ^:(D/ZNZPXN2R?S>66*7;*/3_C
M?HOI$I+@>F?7_J'3\D8'UIQGUN'_`&H%998-?YRW';[+J_\`A<3_`+97<XV3
MCY=#,C&L;=1:-U=C""TC^2X*2$XRV^H.[7S<ODPD<8T/RSCZH2_NR2I)))S"
MI))))2DZ9))3_]#U1!S,S&P<6S+R[&TX]+=UECN`/^_.=^8QOTT8D`$DP!R2
MO)OKA]9W]<S33CN(Z9C.(H':QX]IRG_^Z_\`(_2?X11Y<@A&^O0-CE.6ES&3
MA&D1K.78?]\KZS_7'-ZX]V/07XW3!H*)A]O\K*+?S?\`NO\`0_TF]8>+BY.9
MD5XN)4Z_(M,5U,Y/_?65M_/L?^CK3X6'DY^75AXC/4R+W;:V=O%SG'\VNMOO
ML>O6_JU]6</H.)LKBW*M`.1E$0YY_=;_`*.EOYE:JPA+-(RD=._[`Z^?/BY+
M&(8XCB/RQ_[O(XWU>_Q=X>+LR>L[<S)^DW'&M##_`"@?Z2__`(S]%_P2[%K&
ML:&,`:UHAK1H`!V`"=)7(PC$5$4XF;-DRRXLDN+_`*,?[H4DDF)`!)T`U)3F
M-=,YS6-+G$-:-2XF`%PO7_\`&(_UC@_5ZOUWEWIC++2_<\^W9A8[?Z0[=]"Q
M_P"C_D6,5?%^HG7^M.;E?6//?6':B@GU;`/A_1<;^K578HSELU`<5?XO^,VQ
MR?#$3SS&&)^4$<667_4WLW_6'H%9VOZGB,<.0;ZP?^K1L7JG3<P[<3+HR#X5
M6,>?^@YRP\7_`!=?56AFU^._)/[UMKY_S:337_T%.[_%]]4[![<(U.[/KML!
M!\MSW,_Z*(.3M'[5ACRNPGE\^"%?9[CL]0Z9@=2QSC9]#,BH_FO&H/[S'_3K
M=_*K7&W=(ZS]2[W]1Z.Y^?T4G?F8+S+V-_/M;^]L_P"Y#/?_`-R/4K_3+7KZ
M']8.C'?T?J#L_';ST_J!W2!^;CYK1OI?_H]S/1_TBU>E=8HZFRP!C\?+QG!F
M7AW"+:GD;F[Q^?5:WWT7U_HKF($"1U'#(;%,9RQ@B)&;"?G@=O\`"C_DY?ZQ
M+TOJF'U;"KSL*SU*;1IV+2/I5V-_-L8K:Y/+Q1]4^J?M;$]G0\Y[6=3QA]&B
MQQV59]+?S:MYV9#/_4?H=8G1).AW#%EA$$2@;A+Y;^8=X2_K14DDDG,:DDDD
ME/\`_]'J/\8O6G8/2F]/H=MR.HRQQ'+:&QZY_P"N;FT_VUYCH!X`?@`NC_Q@
MVWO^M-[+A#:Z:FX\Z361O<]O_H0ZYG_6UF?5_I+NL]7Q\$-+JBX/RB/S:6G=
M9N/YN_\`FF?RWJAF)GEX>QX0]!R4(8.5$R1J/=G+^7[KV_U)Z;@]#Z1^VNJ6
MU8M^<T$6WN;6*Z#[JJ@^PMV^K_/V?];_`-&M9WUY^I[7[#U?%GR>"/\`.;[5
MYE_CCZ8<7K^/F>O9:W-JEM#]6U"K;7LH_=J?]/T]O\YO_P!(NF^JG^+CZI]0
M^JF%D9F,ZS*S*199DBQ[7M<__1M:[T?T?YGZ+_C%=C$1B(CHX>;+++DEDEO(
M_8.D7O</.PL^@9&#?7E4.,"VEX>V1R-["YJIV?6CZLU6/JMZMA5V5N+7L=D5
M!S7#1S7-+_:YJ\:^J6=G?5CZ_-Z7C7&RA^;^SLED^RQOJ'%9:YO[]3CZU?\`
MF?0LL4O\:_2.F])^LK*^GTC'9D8[<BUK22#8^RX/>T.+MGT/H-]B<QOMV%U'
MI_4:C=T_*IRZFNVNLH>VQH<-=I=67>[59/UU`MZ#=C?;Z.G.O+6E^3:*6/9(
M]6CU3[F>JS_TE_A%A5YO2/J+]0<?J>!C,;E9M%#FM<7'ULFVIKM]SIW>FS])
M=Z;/39_HO3WKC/J=]5>H?7WJ>1UGKN58_#J?MNMG]);81O\`LU&GIT4U-<UU
MFQOZ-GIU45_I/4I!%@@]5T)&,A(;Q(D+UV>N^IMGU.Z0YUF5U?!NZJ\[0]MH
M].MGT15C6V^FUSG_`.%L_P"M+OVN:]H>PAS7"6N&H(/<%<-U/_$_]5LC#=7@
M"W"R@/T=WJ.L:7=O6KM+MS/^+])<5]2OK3U3ZH_6$]!ZF\_L_P!<XV12XDMI
MLW;/M-!/T:]_OLV_SM/Z3_1I1B(BALG+EGEF9S-R+[>DDJ_4<)G4,&_"LLLI
M9D,-;K*7;+&@_G5V?FN16,&]7Z4[//3&Y=+L\`N.*'M-@`^E-<[E5ZS@O;97
MUC"KGJ&$TZ-T-^/.Z_!?'\YO_G,3?_-9?I_F/N7D?^+_``V87^,UN$QQ>S%M
MRZ6/=R16R^L.=_*=M7N*!%IC(Q-C_?'9`YF+G89:X-OQ<JN"/S7UV#_O['+-
M^K#[J<6[I&2_??TFW[,'DB7T%K;L&YT?O8SV5._X6FU:M%#,>EE%<[*QM8#K
M`'T6_P!E4',-'UB;8##<W$<UX_E8UC75?]#.O_S$#N#]/M7Q-QE'I\T?[T?_
M`$!TTDDDYC4DDDDI_]+TGJ'2>F]28UF?C59(9.SU&AQ;/TMCOI,W;?S4_3^E
M].Z;4:L#&KQF.,N%;0"XCN]WTG_VU:20H7=:KN.7#P\1X?W;]/V/D?\`CP_I
M_2O^)M_ZIBL,ZW_C"P?J[T['^K_3&V8`P*7,S&,-]I<YLVN97NV-=79[/1=C
M7?Z3_"*O_CP_I_2O^*M_ZIB]`^HYGZH=(_\`"M?Y$5KY;_BM=]7K/K&,GK&0
M_P#:SGN^PLM'Z)UKQ_..N).[+<YS_1KL;_.?0]3(])$_QT_^*G&_\)5_^?,A
M8O\`C`]&KZ\]3/3S$7M<#7R+BRM^1MV_X3[7ZO\`UQ;'^.;?_P`YL3?]/[#7
MNCQ]2^4E)O\`&9<\?5KZI4`^PX6\CQ(JQ&M_S=SEVW^*>BNKZD8;V`!U]EUE
MA\7"U]/_`%%+%S?^,#H]N9_B_P"@=3J&X]-QZ!:!VKNJI8Y_]FVNE:/^)KK=
M&1T2[HKW@96%8ZUE9.IIL(=O8/SO3O<_U?W/4I_TB2GT->"_XUZVU_7?,<WF
MQE+W?'TF,_[XO>7O96QUCW!C&`N<YQ@`#5SG.*^?OK#>_P"N'UZN'307MS;V
M8^,1)!KK:VC[1P'-K<RMV2[_`$;$E/NW1KGY'2,&^PR^W&J>\^;F-<Y7%YY]
M9_\`%=F=8ZJ<W%ZI]GH]&JFNA['.V-J8VK8PML;^C=L]7_C+%6Z)_BDZCTWK
M.%U%_5P]F'<RYS&,<'.##N-4FS_"_P`T_P#X-)3S_P!4CM_QK93MP9MR.H'>
M[Z+8&1[WZM]K?ZRUN@=?_P`97U@ZGE8G3.HXUF+B/+7Y[J6"@B?9Z?Z'U'^H
MWZ#-JXZ[IW4NJ?7#J^'TM^S*LNS2&!SFFQC3=9;C-]/Z7KU-=7Z;_P!'9^>N
MZ_Q0?6K%.,?JQD,91E5E]N,\#:;@??=79^]DT_O?GX__`(7]Z4W_`/&!_C!R
MOJ^^KH_2PV[JUC&NNN+9;7N^AZ='NW7V_3V/_FV?Z7U%B=9S_P#&G]6,'&ZW
MU+/HOKL>&68Q94XL<\%PJMV4U?N^_P"R7K&^M3K,;_&H^ZYH<YF9C6UML=L8
MZ&T.I:^YP<VNKVM999_@UT]7U&^M?UMS6Y_UUROLN-6X^ETV@M)`UT9L=910
MW_AMV3E6U_SG^#>DIRNL_P",'ZYCI^/]8.GY%573,U[J1CBIKW8]U8&^BZVV
MO])ZS?T]%F_Z'^#J]-=?T#-^M?5/J2_J)ZGB?M#)!MQ<IU<5U5M(%M>1[&L]
M2MU=['O]&ST_^%5SK/U6Z1U/ZH7]!Z2RIM5+7##%;@YK,BHES=UOZ1WJ.M_1
M9-C_`-+^DM7DO1OK;E=-^JG5OJW%GKYKVMQ0&R6^H?2SZG:[V^I4QC*Z]O\`
M./L24]G]2_K']?.M8^7U7(R:[.FX@?46-H:;'V[-VZEE+6/=]F]2N][?\-_,
M5_\`!]?]6NH=0RS8W)?ZS6MESQM<&/+G!K&WU-KJN]6CT[WUL_HO\U8FZ#C=
M.^J7U<P>GYN15C&MGZ1]KVM#KG_ILC8YVW?^D>[9_P`&M?#SL+-K]7"OJR*@
M8+ZGM>`?`[$+%U>J>&5<5'A[UH__T_5$DDDE/G7UV_Q79_7^JV]5P>H-]2T-
M'V?*W;&;1$4W5^JYE7_!>@J.!]6?\;?3<)O2<+/HKPV`M8X/8[:"=?3MLH=D
ML_L_07J:XCZS=0S:/K+U6JK(M935]6,C(94RQS6MN;:]K<AC6GV7M;[?6_G$
ME-/ZH_XJ6],Z@SJW7,EN;F5/]2JJO<:Q8#O%]EUNVV^S=[_YNOW_`.D6=]9?
M\6GUV^L'5+,[,ZCA7`37CR7U[:0Y[ZJ_3JQMOM]3]^W_`(VQ:'1.K=7OZWT+
MH?4LFUUU6+DOMN8^QK<K&NII?T[,<X^GOOK_`$]%G\Y97DT66^JK_0\$U]=Z
M^W[;G6LZ2:VXC+LNZQ@%N-OLWUV/++/TCW/9O_FTE.K]5.C=<P>BNZ9]8\C'
MZ@T-%%-=;)8,<,%/H7.?75Z^YO\`I*?^N6KD.K?XHLS%SQU'ZIY_V-[7%U=-
MKGL=7,^VC+J]2QS=?3V6L^A_.76+1^HHZA>[IV5EMO=OQO4^TV=6?D"QSF?2
MLZ6[V-W;MWI_]IO^,K65]4LSK%V1]7_5R,O%MS'/N?EY>:_(HS*J]S+\2K#=
MOKJRG;F^GZGI>C77ZGZ6U)3'+^I_^-;K5/V+JG4ZFXAT>QUNUKA_+;B4_IOZ
MMRZSZF_XO^F?59IO#SE]1L&U^4X;0UI_P>/5[O3;^_[M[_\`P-<S9UWK.&<[
M'R,JZS'ZEUEU73;F/?NHLHSJZ\GI]EG^#Q[\'])CL:_TOT>0Q7OK;]9\K'^L
M+[\6_);C_5[T3=BT56OJR77N;9GLR<BK=C5LP^G['U?:?\.^Q)3Z"JW4F=0?
M@7LZ;973G.81CV6@N8U_YKGM;_K_`,'9]!<MU+IM&1]:>F5TY^<,3JM.5DV-
MIS;VUDL^SOH=2VNS;77MN?[*UG]5ZOU*D=7J;F6T8]W7,;"R,L60<3$MKJ]>
MZBVS=7B>[V>K_@O5_?24Y73/\6GU[Z=UMO6Z>HX#<TV.LLM)L=/JS]H_1'%:
MSW[W_P"C_P"MK1^MO^*_.S^N-ZW]7<FG#O>X77ML+Z]M[3O^U8[Z67>ZQWO?
M_P`+^DW_`*7V6,Z^SI.;UOIG3>H9&1ALZ'?FN99<^Y^/D,]E+J<Q[GVT^O6Y
MUWH^I]/].@_5[K76+.O?5[I'4<BQ]^/C9%UMH<_T\K'MIHMZ=E6[]GK6U_IZ
M+-_J_K%%MGJ?I$E)NN_XN.H?6/IF/?U;,I;]8Z&N8_*I811:R7.JJO;%;MS/
M]/557_Q%JHU_53_&M9B#I-_6Z:\$`,=:UY-A9QM;<,=F4_V_Z2ZM6.A?6N^[
MZUUYEN1D/Z9URV[&HIM9:S'I%.UO2[<>ZX?9[+>H>CD>I7C_`.&L6_\`5#J+
MK?VQ7EY?J6-ZQF4T,MLW.:QKVMJHJ:]VYM;/\'4DIN?53ZL8?U8Z2WIV*]UQ
M+C;?<_0V6N#6/>&>[TF;6,:RO_SX_P#2+SGI73.E=<_QJ9N=A`'I73[#F7V$
M^QUK`W<]KOH[+,[??_+J8O1OK=B]>S.AWX?07UUYF1^C?9:XMVU.!%WHN#7_
M`*9WT/\`I_SJ\['3;OJ7]7;NC6V,=UCK3M^6ZDDBK$9[&5[C&YUSC<WZ/^$M
M_P!$FSD(Q,CT9,.*67)'''>1^P=9.?UOJMO6NIW]0N)<U[B,=IU#*0?T-;/W
M?;[W_P#"+<_Q;-O_`.<;C3+:ACO.0!H"-S&U;OY7J?17+:`>`'X!>H_XO>C.
MZ?T8YES=N1U$BT@\MJ`C&8?[)==_UU4\`,\O%V]1=SGIPP\J8`#U#VX1?__4
M]422224I5[NG=/OM?==C4VVVTG&LL>QKG.H<=S\9[W#<['<[_`_S:L))*:XZ
M?@-MIN;C5"W&8:L>P,;NK81M-5+HW55[?S&+$'5:NG?6._I_4\6C&9U6'8>=
M6W:,C:!5]FSGN^EDL^A7_P!M_N+HUG]<Z+A=;Z?9@9C?8[W,L'TF/'T+:_Y3
M4)76FZ_&8<53'I.A(^:']>*L7ZO=`P\AN3A],Q,;(KG9=516Q[9!8[:^MC7-
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MG_BF_P!R7ZSH8_8H'E=S'*/",H'\>!Y'.^O_`$IKJ*?J]TQMN1C--.);96`*
MV':UU>+CT3?Z;VL9[/U9:O0:?K1U#U7]4P,#!P<L[LNIV.?6R01L?Z])N<WW
MU_H]^3[_`/@5U&/A8>*(Q:*J!X5L:S_J`$9(0E=RD3X#0+IYL/#PXL(C_7F?
M<R?][%I8O1>CXF-;B8N#CT8V0"+Z:ZF-98"-CFW,:W;;[#L]ZF_I72W^GOPZ
M'>C4:*IK:=E3AZ;Z*_;[*75^STF^Q6DD]K-=W3\!U%..[&J-&,6.QZBQNRLU
M_P`RZED;:_1_P6SZ"K_\WN@?:_MO[,Q/M?J>M]H]"OU/4GU/6]79ZGJ^I[_4
M5]SFM:7.(:UHESCH`!R25QOUA_QB8>*'8W1MN9D:@Y/^`8?Y)_[5._XO]#_P
MOYB;*<8BY&F3#@R9I<..)D?PC_>+L_6;ZS8G0<3<Z+<RT'[-C3JX_P"DL_<H
M9^>]>2Y>7DYN5;F93S;D7NW6//<\!K1^:QC?96S\Q-DY63EY#\K+M=?D6F;+
M7G4_]]8QOYE;/8Q;GU7^I^9UUXR+MV-TP'W7\/MCZ3,6?S?WLCZ'^C5.<YYI
M<,1IV_:7;P8,7)8C.<AQ'YI?]Q!E]3/JN[K68,G*;_DS%=^DG_"V#W-QV_\`
M!M^ED?\`;7]3U<(.)B8V'C5XN+6VFBENVNMH@`(RMXL8A&AOU+D<US,N8R<1
MTB-(1_='_?/_U?5$DDDE*22224I))))37SNGX?4<9^)FTMOH?])CA_TFGZ3'
MM_?8N'S?J3U[H>0_.^J^78YIU=C[@+(\#O\`U;,:W_AF^JO0$H3)XXRWWZ2'
MS,V'F,F*Q$@P/S8YCBQR_P`%\[Q/\974\2S[+UG`#K6:/V31:/Z^+?\`2=_4
M>MW&_P`8WU9N`]6VW%)Y%U3M/[5/JM6]G]+Z?U&KTL_'KR6#@6-#H_J.^DS^
MRN:S?\6G1+B78=M^$X\-:[U*Q_8OWV?^#)E9H[$3_O;M@3Y')\\)X9=\9XH?
M\YUJOK?]6+1+>IXX_K/V?^?-JD_ZV?5JL$NZGC0/W;`X_<R5Q^1_BMZ@W^C9
M]-O_`!M;J_\`J'7H'_C8]>[9&']]G_I)`Y,P_P`F%XY;D#J.8/U%?]R]3D?X
MPOJM3]#)?D'PIK>?^D]K&+$SO\:+R"WIN!'[MN4[_P!$4R[_`,&5(?XLNO3K
ME8@'>#8?_1;5>QO\5CI!R^I$C\YE-0!^5EK[/_/2:9<Q+:/"R#'\-QZF9R>?
M$?\`H1B\GU7K_6.KS^T<IUE0,BAOLI'A^A9[7[?WKO40^F='ZIU:S9T[&?D`
M&'6#VU-_KWO_`$7]CZ:]-P/J%]6L+:XXQR[&\693O4_\"]N/_P"`KH&,96P,
M8T-8T0UK1``\``@.6E(WDE:9_%,<(\'+XZ'];TQ_Q(O&=!_Q<8>,YF1UEXS;
MA!&,T10T_P`O=[\G^W^C_P""79M:UH#6@``0`-``$Z2L1A&(J(IS<V?)FEQ9
M)&7;M'^Z%))))S&__];U5)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27
MRJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22G_]G_[2#P
M4&AO=&]S:&]P(#,N,``X0DE-!"4``````!``````````````````````.$))
M30/M```````0`&X````!``$`;@````$``3A"24T$)@``````#@``````````
M```_@```.$))300-```````$````>#A"24T$&0``````!````!XX0DE-`_,`
M``````D```````````$`.$))32<0```````*``$``````````CA"24T#]0``
M````2``O9F8``0!L9F8`!@```````0`O9F8``0"AF9H`!@```````0`R````
M`0!:````!@```````0`U`````0`M````!@```````3A"24T#^```````<```
M_____________________________P/H`````/______________________
M______\#Z`````#_____________________________`^@`````________
M_____________________P/H```X0DE-!`@``````!`````!```"0````D``
M````.$))300>```````$`````#A"24T$&@`````#20````8`````````````
M`(````"M````"@!5`&X`=`!I`'0`;`!E`&0`+0`Q`````0``````````````
M```````````!``````````````"M````@``````````````````````!````
M`````````````````````!`````!````````;G5L;`````(````&8F]U;F1S
M3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N9P``````````3&5F
M=&QO;F<``````````$)T;VUL;VYG````@`````!29VAT;&]N9P```*T````&
M<VQI8V5S5FQ,<P````%/8FIC`````0``````!7-L:6-E````$@````=S;&EC
M94E$;&]N9P`````````'9W)O=7!)1&QO;F<`````````!F]R:6=I;F5N=6T`
M```,15-L:6-E3W)I9VEN````#6%U=&]'96YE<F%T960`````5'EP965N=6T`
M```*15-L:6-E5'EP90````!);6<@````!F)O=6YD<T]B:F,````!````````
M4F-T,0````0`````5&]P(&QO;F<``````````$QE9G1L;VYG``````````!"
M=&]M;&]N9P```(``````4F=H=&QO;F<```"M`````W5R;%1%6%0````!````
M````;G5L;%1%6%0````!````````37-G951%6%0````!```````&86QT5&%G
M5$585`````$```````YC96QL5&5X=$ES2%1-3&)O;VP!````"&-E;&Q497AT
M5$585`````$```````EH;W)Z06QI9VYE;G5M````#T53;&EC94AO<GI!;&EG
M;@````=D969A=6QT````"79E<G1!;&EG;F5N=6T````/15-L:6-E5F5R=$%L
M:6=N````!V1E9F%U;'0````+8F=#;VQO<E1Y<&5E;G5M````$453;&EC94)'
M0V]L;W)4>7!E`````$YO;F4````)=&]P3W5T<V5T;&]N9P`````````*;&5F
M=$]U='-E=&QO;F<`````````#&)O='1O;4]U='-E=&QO;F<`````````"W)I
M9VAT3W5T<V5T;&]N9P``````.$))300H```````,`````C_P````````.$))
M3004```````$`````SA"24T$#``````;1@````$```"@````=@```>```-U`
M```;*@`8``'_V/_@`!!*1DE&``$"``!(`$@``/_M``Q!9&]B95]#30`!_^X`
M#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,#`\5&!,3%1,3
M&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`$-"PL-#@T0
M#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,_\``$0@`=@"@`P$B``(1`0,1`?_=``0`"O_$`3\```$%
M`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$``````````0`"
M`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%05%A$R)Q@3(&
M%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B
M9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=WAY>G
MM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R@9$4H;%"
M(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D154V=&7B\K.$
MP]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:
M``P#`0`"$0,1`#\`]422224I),2`).@&I*X[K_\`C%P\0NQ^CL;FWMT.0XG[
M.T_R2SWY7_6OT7_#ILIQB+D:9,6')EEPXXF1_`?WB]B][6-+WD-:T2YQ,`#S
M)6#G_7KZLX+BPY8R+!^9C`V_]-GZ+_P1>8]4ZSU7JSR_J.4^YO(JG94W^K0S
M;7_:=[T_2NA]6ZL8Z=BOMKF#<1LI$<_IG[6?V6*N>9)-0C;I0^%PA'BSY*']
M7TQ_QYO99/\`C3H']#Z;;8/&ZQM7_18+U1?_`(S^L$G9A8S1V#G6./X;$?I_
M^*^YT.ZGG!@[U8K9/_;]X_\`==;>-_BZ^J]+0+:;<HC\ZZU__4TFFO\`Z"('
M,2W(B@S^&X]!`Y/+B/\`TI0><_\`'.ZWWP\7[[`K./\`XTKQ`RNF!P[OIM_)
M7;7_`.C%T[/J;]5F"&],H/\`6;N_ZO<HV_4GZJVSNZ;4)_<W,_\`/3F)PAG'
MZ88SGY`[X)#R/_H;1P_\9'U<R"&Y!NPG'3]-7+?^W*#:U='B9V'FU"[#OKR*
MC^?4X.'P.U<UD_XM?J];K0[(Q3V%=F]OS&2V[_JEA9'^+SZP=,M^U=%S!;8W
MC8XXUQ_D_2=19_URRM'BRQ^:(D/ZNZPXN2R?S>66*7;*/3_C?HOI$I+@>F?7
M_J'3\D8'UIQGUN'_`&H%998-?YRW';[+J_\`A<3_`+97<XV3CY=#,C&L;=1:
M-U=C""TC^2X*2$XRV^H.[7S<ODPD<8T/RSCZH2_NR2I)))S"I))))2DZ9))3
M_]#U1!S,S&P<6S+R[&TX]+=UECN`/^_.=^8QOTT8D`$DP!R2O)OKA]9W]<S3
M3CN(Z9C.(H':QX]IRG_^Z_\`(_2?X11Y<@A&^O0-CE.6ES&3A&D1K.78?]\K
MZS_7'-ZX]V/07XW3!H*)A]O\K*+?S?\`NO\`0_TF]8>+BY.9D5XN)4Z_(M,5
MU,Y/_?65M_/L?^CK3X6'DY^75AXC/4R+W;:V=O%SG'\VNMOOL>O6_JU]6</H
M.)LKBW*M`.1E$0YY_=;_`*.EOYE:JPA+-(RD=._[`Z^?/BY+&(8XCB/RQ_[O
M(XWU>_Q=X>+LR>L[<S)^DW'&M##_`"@?Z2__`(S]%_P2[%K&L:&,`:UHAK1H
M`!V`"=)7(PC$5$4XF;-DRRXLDN+_`*,?[H4DDF)`!)T`U)3F-=,YS6-+G$-:
M-2XF`%PO7_\`&(_UC@_5ZOUWEWIC++2_<\^W9A8[?Z0[=]"Q_P"C_D6,5?%^
MHG7^M.;E?6//?6':B@GU;`/A_1<;^K578HSELU`<5?XO^,VQR?#$3SS&&)^4
M$<667_4WLW_6'H%9VOZGB,<.0;ZP?^K1L7JG3<P[<3+HR#X56,>?^@YRP\7_
M`!=?56AFU^._)/[UMKY_S:337_T%.[_%]]4[![<(U.[/KML!!\MSW,_Z*(.3
MM'[5ACRNPGE\^"%?9[CL]0Z9@=2QSC9]#,BH_FO&H/[S'_3K=_*K7&W=(ZS]
M2[W]1Z.Y^?T4G?F8+S+V-_/M;^]L_P"Y#/?_`-R/4K_3+7KZ']8.C'?T?J#L
M_';ST_J!W2!^;CYK1OI?_H]S/1_TBU>E=8HZFRP!C\?+QG!F7AW"+:GD;F[Q
M^?5:WWT7U_HKF($"1U'#(;%,9RQ@B)&;"?G@=O\`"C_DY?ZQ+TOJF'U;"KSL
M*SU*;1IV+2/I5V-_-L8K:Y/+Q1]4^J?M;$]G0\Y[6=3QA]&BQQV59]+?S:MY
MV9#/_4?H=8G1).AW#%EA$$2@;A+Y;^8=X2_K14DDDG,:DDDDE/\`_]'J/\8O
M6G8/2F]/H=MR.HRQQ'+:&QZY_P"N;FT_VUYCH!X`?@`NC_Q@VWO^M-[+A#:Z
M:FX\Z361O<]O_H0ZYG_6UF?5_I+NL]7Q\$-+JBX/RB/S:6G=9N/YN_\`FF?R
MWJAF)GEX>QX0]!R4(8.5$R1J/=G+^7[KV_U)Z;@]#Z1^VNJ6U8M^<T$6WN;6
M*Z#[JJ@^PMV^K_/V?];_`-&M9WUY^I[7[#U?%GR>"/\`.;[5YE_CCZ8<7K^/
MF>O9:W-JEM#]6U"K;7LH_=J?]/T]O\YO_P!(NF^JG^+CZI]0^JF%D9F,ZS*S
M*199DBQ[7M<__1M:[T?T?YGZ+_C%=C$1B(CHX>;+++DEDEO(_8.D7O</.PL^
M@9&#?7E4.,"VEX>V1R-["YJIV?6CZLU6/JMZMA5V5N+7L=D5!S7#1S7-+_:Y
MJ\:^J6=G?5CZ_-Z7C7&RA^;^SLED^RQOJ'%9:YO[]3CZU?\`F?0LL4O\:_2.
MF])^LK*^GTC'9D8[<BUK22#8^RX/>T.+MGT/H-]B<QOMV%U'I_4:C=T_*IRZ
MFNVNLH>VQH<-=I=67>[59/UU`MZ#=C?;Z.G.O+6E^3:*6/9(]6CU3[F>JS_T
ME_A%A5YO2/J+]0<?J>!C,;E9M%#FM<7'ULFVIKM]SIW>FS])=Z;/39_HO3WK
MC/J=]5>H?7WJ>1UGKN58_#J?MNMG]);81O\`LU&GIT4U-<UUFQOZ-GIU45_I
M/4I!%@@]5T)&,A(;Q(D+UV>N^IMGU.Z0YUF5U?!NZJ\[0]MH].MGT15C6V^F
MUSG_`.%L_P"M+OVN:]H>PAS7"6N&H(/<%<-U/_$_]5LC#=7@"W"R@/T=WJ.L
M:7=O6KM+MS/^+])<5]2OK3U3ZH_6$]!ZF\_L_P!<XV12XDMILW;/M-!/T:]_
MOLV_SM/Z3_1I1B(BALG+EGEF9S-R+[>DDJ_4<)G4,&_"LLLI9D,-;K*7;+&@
M_G5V?FN16,&]7Z4[//3&Y=+L\`N.*'M-@`^E-<[E5ZS@O;97UC"KGJ&$TZ-T
M-^/.Z_!?'\YO_G,3?_-9?I_F/N7D?^+_``V87^,UN$QQ>S%MRZ6/=R16R^L.
M=_*=M7N*!%IC(Q-C_?'9`YF+G89:X-OQ<JN"/S7UV#_O['+-^K#[J<6[I&2_
M??TFW[,'DB7T%K;L&YT?O8SV5._X6FU:M%#,>EE%<[*QM8#K`'T6_P!E4',-
M'UB;8##<W$<UX_E8UC75?]#.O_S$#N#]/M7Q-QE'I\T?[T?_`$!TTDDDYC4D
MDDDI_]+TGJ'2>F]28UF?C59(9.SU&AQ;/TMCOI,W;?S4_3^E].Z;4:L#&KQF
M.,N%;0"XCN]WTG_VU:20H7=:KN.7#P\1X?W;]/V/D?\`CP_I_2O^)M_ZIBL,
MZW_C"P?J[T['^K_3&V8`P*7,S&,-]I<YLVN97NV-=79[/1=C7?Z3_"*O_CP_
MI_2O^*M_ZIB]`^HYGZH=(_\`"M?Y$5KY;_BM=]7K/K&,GK&0_P#:SGN^PLM'
MZ)UKQ_..N).[+<YS_1KL;_.?0]3(])$_QT_^*G&_\)5_^?,A8O\`C`]&KZ\]
M3/3S$7M<#7R+BRM^1MV_X3[7ZO\`UQ;'^.;?_P`YL3?]/[#7NCQ]2^4E)O\`
M&9<\?5KZI4`^PX6\CQ(JQ&M_S=SEVW^*>BNKZD8;V`!U]EUEA\7"U]/_`%%+
M%S?^,#H]N9_B_P"@=3J&X]-QZ!:!VKNJI8Y_]FVNE:/^)KK=&1T2[HKW@96%
M8ZUE9.IIL(=O8/SO3O<_U?W/4I_TB2GT->"_XUZVU_7?,<WFQE+W?'TF,_[X
MO>7O96QUCW!C&`N<YQ@`#5SG.*^?OK#>_P"N'UZN'307MS;V8^,1)!KK:VC[
M1P'-K<RMV2[_`$;$E/NW1KGY'2,&^PR^W&J>\^;F-<Y7%YY]9_\`%=F=8ZJ<
MW%ZI]GH]&JFNA['.V-J8VK8PML;^C=L]7_C+%6Z)_BDZCTWK.%U%_5P]F'<R
MYS&,<'.##N-4FS_"_P`T_P#X-)3S_P!4CM_QK93MP9MR.H'>[Z+8&1[WZM]K
M?ZRUN@=?_P`97U@ZGE8G3.HXUF+B/+7Y[J6"@B?9Z?Z'U'^HWZ#-JXZ[IW4N
MJ?7#J^'TM^S*LNS2&!SFFQC3=9;C-]/Z7KU-=7Z;_P!'9^>NZ_Q0?6K%.,?J
MQD,91E5E]N,\#:;@??=79^]DT_O?GX__`(7]Z4W_`/&!_C!ROJ^^KH_2PV[J
MUC&NNN+9;7N^AZ='NW7V_3V/_FV?Z7U%B=9S_P#&G]6,'&ZWU+/HOKL>&68Q
M94XL<\%PJMV4U?N^_P"R7K&^M3K,;_&H^ZYH<YF9C6UML=L8Z&T.I:^YP<VN
MKVM999_@UT]7U&^M?UMS6Y_UUROLN-6X^ETV@M)`UT9L=910W_AMV3E6U_SG
M^#>DIRNL_P",'ZYCI^/]8.GY%573,U[J1CBIKW8]U8&^BZVVO])ZS?T]%F_Z
M'^#J]-=?T#-^M?5/J2_J)ZGB?M#)!MQ<IU<5U5M(%M>1[&L]2MU=['O]&ST_
M^%5SK/U6Z1U/ZH7]!Z2RIM5+7##%;@YK,BHES=UOZ1WJ.M_19-C_`-+^DM7D
MO1OK;E=-^JG5OJW%GKYKVMQ0&R6^H?2SZG:[V^I4QC*Z]O\`./L24]G]2_K'
M]?.M8^7U7(R:[.FX@?46-H:;'V[-VZEE+6/=]F]2N][?\-_,5_\`!]?]6NH=
M0RS8W)?ZS6MESQM<&/+G!K&WU-KJN]6CT[WUL_HO\U8FZ#C=.^J7U<P>GYN1
M5C&MGZ1]KVM#KG_ILC8YVW?^D>[9_P`&M?#SL+-K]7"OJR*@8+ZGM>`?`[$+
M%U>J>&5<5'A[UH__T_5$DDDE/G7UV_Q79_7^JV]5P>H-]2T-'V?*W;&;1$4W
M5^JYE7_!>@J.!]6?\;?3<)O2<+/HKPV`M8X/8[:"=?3MLH=DL_L_07J:XCZS
M=0S:/K+U6JK(M935]6,C(94RQS6MN;:]K<AC6GV7M;[?6_G$E-/ZH_XJ6],Z
M@SJW7,EN;F5/]2JJO<:Q8#O%]EUNVV^S=[_YNOW_`.D6=]9?\6GUV^L'5+,[
M,ZCA7`37CR7U[:0Y[ZJ_3JQMOM]3]^W_`(VQ:'1.K=7OZWT+H?4LFUUU6+DO
MMN8^QK<K&NII?T[,<X^GOOK_`$]%G\Y97DT66^JK_0\$U]=Z^W[;G6LZ2:VX
MC+LNZQ@%N-OLWUV/++/TCW/9O_FTE.K]5.C=<P>BNZ9]8\C'Z@T-%%-=;)8,
M<,%/H7.?75Z^YO\`I*?^N6KD.K?XHLS%SQU'ZIY_V-[7%U=-KGL=7,^VC+J]
M2QS=?3V6L^A_.76+1^HHZA>[IV5EMO=OQO4^TV=6?D"QSF?2LZ6[V-W;MWI_
M]IO^,K65]4LSK%V1]7_5R,O%MS'/N?EY>:_(HS*J]S+\2K#=OKJRG;F^GZGI
M>C77ZGZ6U)3'+^I_^-;K5/V+JG4ZFXAT>QUNUKA_+;B4_IOZMRZSZF_XO^F?
M59IO#SE]1L&U^4X;0UI_P>/5[O3;^_[M[_\`P-<S9UWK.&<['R,JZS'ZEUEU
M73;F/?NHLHSJZ\GI]EG^#Q[\'])CL:_TOT>0Q7OK;]9\K'^L+[\6_);C_5[T
M3=BT56OJR77N;9GLR<BK=C5LP^G['U?:?\.^Q)3Z"JW4F=0?@7LZ;973G.81
MCV6@N8U_YKGM;_K_`,'9]!<MU+IM&1]:>F5TY^<,3JM.5DV-IS;VUDL^SOH=
M2VNS;77MN?[*UG]5ZOU*D=7J;F6T8]W7,;"R,L60<3$MKJ]>ZBVS=7B>[V>K
M_@O5_?24Y73/\6GU[Z=UMO6Z>HX#<TV.LLM)L=/JS]H_1'%:SW[W_P"C_P"M
MK1^MO^*_.S^N-ZW]7<FG#O>X77ML+Z]M[3O^U8[Z67>ZQWO?_P`+^DW_`*7V
M6,Z^SI.;UOIG3>H9&1ALZ'?FN99<^Y^/D,]E+J<Q[GVT^O6YUWH^I]/].@_5
M[K76+.O?5[I'4<BQ]^/C9%UMH<_T\K'MIHMZ=E6[]GK6U_IZ+-_J_K%%MGJ?
MI$E)NN_XN.H?6/IF/?U;,I;]8Z&N8_*I811:R7.JJO;%;MS/]/557_Q%JHU_
M53_&M9B#I-_6Z:\$`,=:UY-A9QM;<,=F4_V_Z2ZM6.A?6N^[ZUUYEN1D/Z9U
MRV[&HIM9:S'I%.UO2[<>ZX?9[+>H>CD>I7C_`.&L6_\`5#J+K?VQ7EY?J6-Z
MQF4T,MLW.:QKVMJHJ:]VYM;/\'4DIN?53ZL8?U8Z2WIV*]UQ+C;?<_0V6N#6
M/>&>[TF;6,:RO_SX_P#2+SGI73.E=<_QJ9N=A`'I73[#F7V$^QUK`W<]KOH[
M+,[??_+J8O1OK=B]>S.AWX?07UUYF1^C?9:XMVU.!%WHN#7_`*9WT/\`I_SJ
M\['3;OJ7]7;NC6V,=UCK3M^6ZDDBK$9[&5[C&YUSC<WZ/^$M_P!$FSD(Q,CT
M9,.*67)'''>1^P=9.?UOJMO6NIW]0N)<U[B,=IU#*0?T-;/W?;[W_P#"+<_Q
M;-O_`.<;C3+:ACO.0!H"-S&U;OY7J?17+:`>`'X!>H_XO>C.Z?T8YES=N1U$
MBT@\MJ`C&8?[)==_UU4\`,\O%V]1=SGIPP\J8`#U#VX1?__4]422224I5[NG
M=/OM?==C4VVVTG&LL>QKG.H<=S\9[W#<['<[_`_S:L))*:XZ?@-MIN;C5"W&
M8:L>P,;NK81M-5+HW55[?S&+$'5:NG?6._I_4\6C&9U6'8>=6W:,C:!5]FSG
MN^EDL^A7_P!M_N+HUG]<Z+A=;Z?9@9C?8[W,L'TF/'T+:_Y34)76FZ_&8<53
M'I.A(^:']>*L7ZO=`P\AN3A],Q,;(KG9=516Q[9!8[:^MC7-W,=L61GMS>E.
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M8_8H'E=S'*/",H'\>!Y'.^O_`$IKJ*?J]TQMN1C--.);96`*V':UU>+CT3?Z
M;VL9[/U9:O0:?K1U#U7]4P,#!P<L[LNIV.?6R01L?Z])N<WWU_H]^3[_`/@5
MU&/A8>*(Q:*J!X5L:S_J`$9(0E=RD3X#0+IYL/#PXL(C_7F?<R?][%I8O1>C
MXF-;B8N#CT8V0"+Z:ZF-98"-CFW,:W;;[#L]ZF_I72W^GOPZ'>C4:*IK:=E3
MAZ;Z*_;[*75^STF^Q6DD]K-=W3\!U%..[&J-&,6.QZBQNRLU_P`RZED;:_1_
MP6SZ"K_\WN@?:_MO[,Q/M?J>M]H]"OU/4GU/6]79ZGJ^I[_45]SFM:7.(:UH
MESCH`!R25QOUA_QB8>*'8W1MN9D:@Y/^`8?Y)_[5._XO]#_POYB;*<8BY&F3
M#@R9I<..)D?PC_>+L_6;ZS8G0<3<Z+<RT'[-C3JX_P"DL_<H9^>]>2Y>7DYN
M5;F93S;D7NW6//<\!K1^:QC?96S\Q-DY63EY#\K+M=?D6F;+7G4_]]8QOYE;
M/8Q;GU7^I^9UUXR+MV-TP'W7\/MCZ3,6?S?WLCZ'^C5.<YYI<,1IV_:7;P8,
M7)8C.<AQ'YI?]Q!E]3/JN[K68,G*;_DS%=^DG_"V#W-QV_\`!M^ED?\`;7]3
MU<(.)B8V'C5XN+6VFBENVNMH@`(RMXL8A&AOU+D<US,N8R<1TB-(1_='_?/_
MU?5$DDDE*22224I))))37SNGX?4<9^)FTMOH?])CA_TFGZ3'M_?8N'S?J3U[
MH>0_.^J^78YIU=C[@+(\#O\`U;,:W_AF^JO0$H3)XXRWWZ2'S,V'F,F*Q$@P
M/S8YCBQR_P`%\[Q/\974\2S[+UG`#K6:/V31:/Z^+?\`2=_4>MW&_P`8WU9N
M`]6VW%)Y%U3M/[5/JM6]G]+Z?U&KTL_'KR6#@6-#H_J.^DS^RN:S?\6G1+B7
M8=M^$X\-:[U*Q_8OWV?^#)E9H[$3_O;M@3Y')\\)X9=\9XH?\YUJOK?]6+1+
M>IXX_K/V?^?-JD_ZV?5JL$NZGC0/W;`X_<R5Q^1_BMZ@W^C9]-O_`!M;J_\`
MJ'7H'_C8]>[9&']]G_I)`Y,P_P`F%XY;D#J.8/U%?]R]3D?XPOJM3]#)?D'P
MIK>?^D]K&+$SO\:+R"WIN!'[MN4[_P!$4R[_`,&5(?XLNO3KE8@'>#8?_1;5
M>QO\5CI!R^I$C\YE-0!^5EK[/_/2:9<Q+:/"R#'\-QZF9R>?$?\`H1B\GU7K
M_6.KS^T<IUE0,BAOLI'A^A9[7[?WKO40^F='ZIU:S9T[&?D`&'6#VU-_KWO_
M`$7]CZ:]-P/J%]6L+:XXQR[&\693O4_\"]N/_P"`KH&,96P,8T-8T0UK1``\
M``@.6E(WDE:9_%,<(\'+XZ'];TQ_Q(O&=!_Q<8>,YF1UEXS;A!&,T10T_P`O
M=[\G^W^C_P""79M:UH#6@``0`-``$Z2L1A&(J(IS<V?)FEQ9)&7;M'^Z%)))
M)S&__];U5)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI
M)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22G_]DX0DE-!"$``````%4`
M```!`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'`````3`$$`
M9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"``0P!3`#0````!`#A"24T$
M!@``````!P`(`````0$`_^$0:6AT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"\`/#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#96AI2'IR95-Z
M3E1C>FMC.60B/SX@/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN<SIM971A
M+R(@>#IX;7!T:STB061O8F4@6$U0($-O<F4@-"XR+C(M8S`V,R`U,RXS-3(V
M,C0L(#(P,#@O,#<O,S`M,3@Z,3(Z,3@@("`@("`@("(^(#QR9&8Z4D1&('AM
M;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN
M=&%X+6YS(R(^(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS
M.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+R(@>&UL;G,Z9&,]
M(FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(B!X;6QN<SIX;7!-
M33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+VUM+R(@>&UL;G,Z<W1%
M=G0](FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C
M945V96YT(R(@>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N8V]M
M+W!H;W1O<VAO<"\Q+C`O(B!X;6QN<SIT:69F/2)H='1P.B\O;G,N861O8F4N
M8V]M+W1I9F8O,2XP+R(@>&UL;G,Z97AI9CTB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]E>&EF+S$N,"\B('AM<#I#<F5A=&]R5&]O;#TB061O8F4@4&AO=&]S:&]P
M($-3-"!7:6YD;W=S(B!X;7`Z0W)E871E1&%T93TB,C`Q,BTP-"TQ,U0Q,3HS
M,#HP-BTP-CHP,"(@>&UP.DUE=&%D871A1&%T93TB,C`Q,BTP-"TQ,U0Q,3HS
M,#HP-BTP-CHP,"(@>&UP.DUO9&EF>41A=&4](C(P,3(M,#0M,3-4,3$Z,S`Z
M,#8M,#8Z,#`B(&1C.F9O<FUA=#TB:6UA9V4O:G!E9R(@>&UP34TZ26YS=&%N
M8V5)1#TB>&UP+FEI9#I"04$W-41!-41#.#1%,3$Q03DX1$$V0D-#,C8S-41#
M,"(@>&UP34TZ1&]C=6UE;G1)1#TB>&UP+F1I9#I"04$W-41!-41#.#1%,3$Q
M03DX1$$V0D-#,C8S-41#,"(@>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/2)X
M;7`N9&ED.D)!03<U1$$U1$,X-$4Q,3%!.3A$039"0T,R-C,U1$,P(B!P:&]T
M;W-H;W`Z0V]L;W)-;V1E/2(S(B!P:&]T;W-H;W`Z24-#4')O9FEL93TB<U)'
M0B!)14,V,3DV-BTR+C$B('1I9F8Z3W)I96YT871I;VX](C$B('1I9F8Z6%)E
M<V]L=71I;VX](C$Q,#`P,#`O,3`P,#`B('1I9F8Z65)E<V]L=71I;VX](C$Q
M,#`P,#`O,3`P,#`B('1I9F8Z4F5S;VQU=&EO;E5N:70](C(B('1I9F8Z3F%T
M:79E1&EG97-T/2(R-38L,C4W+#(U."PR-3DL,C8R+#(W-"PR-S<L,C@T+#4S
M,"PU,S$L,C@R+#(X,RPR.38L,S`Q+#,Q."PS,3DL-3(Y+#4S,BPS,#8L,C<P
M+#(W,2PR-S(L,S`U+#,Q-2PS,S0S,CM%,C4X.3E&-S1%-SDX1C@V,D5#13DV
M.#@X1#,U1$%%."(@97AI9CI0:7AE;%A$:6UE;G-I;VX](C$W,R(@97AI9CI0
M:7AE;%E$:6UE;G-I;VX](C$R."(@97AI9CI#;VQO<E-P86-E/2(Q(B!E>&EF
M.DYA=&EV941I9V5S=#TB,S8X-C0L-#`Y-C`L-#`Y-C$L,S<Q,C$L,S<Q,C(L
M-#`Y-C(L-#`Y-C,L,S<U,3`L-#`Y-C0L,S8X-C<L,S8X-C@L,S,T,S0L,S,T
M,S<L,S0X-3`L,S0X-3(L,S0X-34L,S0X-38L,S<S-S<L,S<S-S@L,S<S-SDL
M,S<S.#`L,S<S.#$L,S<S.#(L,S<S.#,L,S<S.#0L,S<S.#4L,S<S.#8L,S<S
M.38L-#$T.#,L-#$T.#0L-#$T.#8L-#$T.#<L-#$T.#@L-#$T.3(L-#$T.3,L
M-#$T.34L-#$W,C@L-#$W,CDL-#$W,S`L-#$Y.#4L-#$Y.#8L-#$Y.#<L-#$Y
M.#@L-#$Y.#DL-#$Y.3`L-#$Y.3$L-#$Y.3(L-#$Y.3,L-#$Y.30L-#$Y.34L
M-#$Y.38L-#(P,38L,"PR+#0L-2PV+#<L."PY+#$P+#$Q+#$R+#$S+#$T+#$U
M+#$V+#$W+#$X+#(P+#(R+#(S+#(T+#(U+#(V+#(W+#(X+#,P.T$S-$$P-SA$
M.#<U,#@Q,#$R-4)&-$8S-#=!-S9".#)!(CX@/'AM<$U-.DAI<W1O<GD^(#QR
M9&8Z4V5Q/B`\<F1F.FQI('-T179T.F%C=&EO;CTB8W)E871E9"(@<W1%=G0Z
M:6YS=&%N8V5)1#TB>&UP+FEI9#I"04$W-41!-41#.#1%,3$Q03DX1$$V0D-#
M,C8S-41#,"(@<W1%=G0Z=VAE;CTB,C`Q,BTP-"TQ,U0Q,3HS,#HP-BTP-CHP
M,"(@<W1%=G0Z<V]F='=A<F5!9V5N=#TB061O8F4@4&AO=&]S:&]P($-3-"!7
M:6YD;W=S(B\^(#PO<F1F.E-E<3X@/"]X;7!-33I(:7-T;W)Y/B`\+W)D9CI$
M97-C<FEP=&EO;CX@/"]R9&8Z4D1&/B`\+W@Z>&UP;65T83X@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`\/WAP86-K970@96YD/2)W(C\^_^(,6$E#0U]04D]&
M24Q%``$!```,2$QI;F\"$```;6YT<E)'0B!865H@!\X``@`)``8`,0``86-S
M<$U31E0`````245#('-21T(```````````````$``/;6``$`````TRU(4"`@
M````````````````````````````````````````````````````````````
M```18W!R=````5`````S9&5S8P```80```!L=W1P=````?`````48FMP=```
M`@0````4<EA96@```A@````49UA96@```BP````48EA96@```D`````49&UN
M9````E0```!P9&UD9````L0```"(=G5E9````TP```"&=FEE=P```]0````D
M;'5M:0```_@````4;65A<P``!`P````D=&5C:```!#`````,<E120P``!#P`
M``@,9U120P``!#P```@,8E120P``!#P```@,=&5X=`````!#;W!Y<FEG:'0@
M*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD``&1E<V,`````````
M$G-21T(@245#-C$Y-C8M,BXQ```````````````2<U)'0B!)14,V,3DV-BTR
M+C$`````````````````````````````````````````````````````````
M`````````%A96B````````#S40`!`````1;,6%E:(```````````````````
M``!865H@````````;Z(``#CU```#D%A96B````````!BF0``MX4``!C:6%E:
M(````````"2@```/A```ML]D97-C`````````!9)14,@:'1T<#HO+W=W=RYI
M96,N8V@``````````````!9)14,@:'1T<#HO+W=W=RYI96,N8V@`````````
M````````````````````````````````````````````````````9&5S8P``
M```````N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@
M+2!S4D="```````````````N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C
M;VQO=7(@<W!A8V4@+2!S4D="`````````````````````````````&1E<V,`
M````````+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV
M-BTR+C$``````````````"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@
M:6X@245#-C$Y-C8M,BXQ``````````````````````````````````!V:65W
M```````3I/X`%%\N`!#/%``#[<P`!!,+``-<G@````%865H@``````!,"58`
M4````%<?YVUE87,``````````0````````````````````````*/`````G-I
M9R``````0U)4(&-U<G8````````$``````4`"@`/`!0`&0`>`",`*``M`#(`
M-P`[`$``10!*`$\`5`!9`%X`8P!H`&T`<@!W`'P`@0"&`(L`D`"5`)H`GP"D
M`*D`K@"R`+<`O`#!`,8`RP#0`-4`VP#@`.4`ZP#P`/8`^P$!`0<!#0$3`1D!
M'P$E`2L!,@$X`3X!10%,`5(!60%@`6<!;@%U`7P!@P&+`9(!F@&A`:D!L0&Y
M`<$!R0'1`=D!X0'I`?(!^@(#`@P"%`(=`B8"+P(X`D$"2P)4`ET"9P)Q`GH"
MA`*.`I@"H@*L`K8"P0++`M4"X`+K`O4#``,+`Q8#(0,M`S@#0P-/`UH#9@-R
M`WX#B@.6`Z(#K@.Z`\<#TP/@`^P#^00&!!,$(`0M!#L$2`15!&,$<01^!(P$
MF@2H!+8$Q`33!.$$\`3^!0T%'`4K!3H%2058!6<%=P6&!98%I@6U!<4%U07E
M!?8&!@86!B<&-P9(!ED&:@9[!HP&G0:O!L`&T0;C!O4'!P<9!RL'/0=/!V$'
M=`>&!YD'K`>_!]('Y0?X"`L('P@R"$8(6@AN"(((E@BJ"+X(T@CG"/L)$`DE
M"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5`IJ"H$*F`JN"L4*W`KS"PL+
M(@LY"U$+:0N`"Y@+L`O("^$+^0P2#"H,0PQ<#'4,C@RG#,`,V0SS#0T-)@U`
M#5H-=`V.#:D-PPW>#?@.$PXN#DD.9`Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/
MLP_/#^P0"1`F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%
M$F02A!*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5
M-!56%7@5FQ6]%>`6`Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA`
M&&48BABO&-48^AD@&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC&XH;
MLAO:'`(<*AQ2''L<HQS,'/4='AU''7`=F1W#'>P>%AY`'FH>E!Z^'ND?$Q\^
M'VD?E!^_'^H@%2!!(&P@F"#$(/`A'"%((74AH2'.(?LB)R)5(H(BKR+=(PHC
M."-F(Y0CPB/P)!\D321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W)N@G&"=)
M)WHGJR?<*`TH/RAQ**(HU"D&*3@I:RF=*=`J`BHU*F@JFRK/*P(K-BMI*YTK
MT2P%+#DL;BRB+-<M#"U!+78MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'+_XP-3!L
M,*0PVS$2,4HQ@C&Z,?(R*C)C,ILRU#,-,T8S?S.X,_$T*S1E-)XTV#43-4TU
MAS7"-?TV-S9R-JXVZ3<D-V`WG#?7.!0X4#B,.,@Y!3E".7\YO#GY.C8Z=#JR
M.N\[+3MK.ZH[Z#PG/&4\I#SC/2(]83VA/>`^(#Y@/J`^X#\A/V$_HC_B0"-`
M9$"F0.=!*4%J0:Q![D(P0G)"M4+W0SI#?4/`1`-$1T2*1,Y%$D5519I%WD8B
M1F=&JT;P1S5'>T?`2`5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB3"I,
M<DRZ30)-2DV33=Q.)4YN3K=/`$])3Y-/W5`G4'%0NU$&45!1FU'F4C%2?%+'
M4Q-37U.J4_940E2/5-M5*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RUD:66E9
MN%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8`5@5V"J
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M,XF9B?Z*9(K*BS"+EHO\C&.,RHTQC9B-_XYFCLZ/-H^>D`:0;I#6D3^1J)(1
MDGJ2XY--D[:4()2*E/257Y7)EC26GY<*EW67X)A,F+B9))F0F?R::)K5FT*;
MKYP<G(F<]YUDG=*>0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%:DQZ4X
MI:FF&J:+IOVG;J?@J%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:O
MB[``L'6PZK%@L=:R2[+"LSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-&Y2KG"
MNCNZM;LNNZ>\(;R;O16]C[X*OH2^_[]ZO_7`<,#LP6?!X\)?PMO#6,/4Q%'$
MSL5+Q<C&1L;#QT''O\@]R+S).LFYRCC*M\LVR[;,-<RUS37-M<XVSK;/-\^X
MT#G0NM$\T;[2/]+!TT33QM1)U,O53M71UE76V-=<U^#89-CHV6S9\=IVVOO;
M@-P%W(K=$-V6WAS>HM\IWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@WFEN<?
MYZGH,NB\Z4;IT.I;ZN7K<.O[[(;M$>V<[BCNM.]`[\SP6/#E\7+Q__*,\QGS
MI_0T],+U4/7>]FWV^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?__
M_^X`#D%D;V)E`&1``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!
M`0$!`0$!`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#_\``$0@`@`"M`P$1``(1`0,1`?_=``0`%O_$`:(`
M```&`@,!``````````````<(!@4$"0,*`@$`"P$```8#`0$!````````````
M!@4$`P<""`$)``H+$``"`0,$`0,#`@,#`P(&"74!`@,$$042!B$'$R(`"#$4
M03(C%0E10A9A)#,74G&!&&*1)4.AL?`F-'(*&<'1-2?A4S:"\9*B1%1S148W
M1V,H5597&K+"TN+R9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY
M>H6&AXB)BI25EI>8F9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7F
MY^CIZO3U]O?X^?H1``(!`P($!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R
M811Q"$*!(Y$54J%B%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS
M@Y-&=,+2XO)59756-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6
MIK;&UN;V9W>'EZ>WQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI:
M:GJ*FJJZRMKJ^O_:``P#`0`"$0,1`#\`W]2]C:W^\_\`&O?NO==>3_#_`'G_
M`(U[]U[KWD_P_P!Y_P"->_=>Z]Y/\/\`>?\`C7OW7NO>3_#_`'G_`(U[]UZH
M/GT#W;7R$Z2Z%PDFY.Z^U^ONJ\(BLZUN^MUXC;AJ0H)T8^DR-3!69*=M/ICI
MXY)&_`/M!N&Z[9M41GW*_BAC_IL!_+B?R'1]L'*O-'-=XMARQR]>7UU7A#$\
MG\U!`X'B>JC^U_\`A1#_`"Z^O)ZBBVEGNSNZJV(2K'+UOU_6TV$>:/@1MF]^
MU>S(C&Y^DD,<ZVY%_<=;E[P\GV)989IKAAQT+BOVDC_!UDARM]S/WLYB2&:\
MVRTVV!N/U,WZ@!\S%$LC`_(TZKWWS_PJ-IBL\76?PZKG<.ZT];V!VW1TD<L0
M/HDEQ^V=I9)X69?J@J7M_JC[!U][[V]/]UVQ25]96('_`!D=37MG]WYN">&>
M8_<2&-VX+!:NQ^8U2NE/MTTZ!5O^%07R`+$Q_%'IR-"`55^PM[RLOX*EUQ$0
M;D?72./92??3=&J4V&V(_P!._0Q7^[_Y+"#5[B[DTE,Z8(:?S;RZG8__`(5"
M]X1U,;93XD]555+Y!YEQ_9N[Z*H$7`81M5;<R$7D/XNMOZ^]Q^^>Z$KKV"WT
M_)WZ37G]W_RUX8%A[D7JR?\`#+>(T^=%=?\`#T;#KK_A4#T7DIZ>G[6^,/;6
MRX#&OW.4V3NC:78$2RD>OQX[)?W'K/$#]/4S6_'L26OOKLS%([S9KF-_,BA7
MJ.MY^X'SM"D\G+G.NW7@'PK)'+$3\BR>,H/VTZLOZ0_G7?RX^]9Z+&XGY`8G
MKS<->46#;G<F+R?6=9YG(40?QG.P+L^6<L0`L>3D+$\7]CO;/<GD_=&2*/=5
MBN&--$HTG_*/Y]8^\W?=E][>3C*]YR3/=6B`_J6A%RN..$[AC/<H/RZM$Q6;
MQ>=H:;*83(4&8Q5;"D]'E,56TV0QU9"X!26DK:.2:EJ(G4W#(Y!]CF.2.5!+
M#(KQ'@000?V=01-%-;3RVMS"\=S&:,K*5(/H0P!J/,>73EY/\/\`>?\`C7NW
M'AU09X=>\G^'^\_\:]^Z]U[R?X?[S_QKW[KW7O)_A_O/_&O?NO=>\G^'^\_\
M:]^Z]U[R?X?[S_QKW[KW7O)_A_O/_&O?NO=>\G^'^\_\:]^Z]USOQ?\`PO\`
M[Q[]U[K_T-_)_P!1_P!A_O0]^Z]UQ]^Z]UZX'U-O?J@4KU[HGORZ^=WQD^$6
MSX=U=^]BT6!K,I#+)M78N'C.<[&WH\1,93:^T:)_OZJG27TR5L_V^/IS_G9T
MXN'.8>:]DY7MFN=WNPAIVH,R/]B_Y3CJ1?;OVJY[]U-S?:N2]BDN2G]K,:)!
M"/,R2-113^$5<^2GK49^8?\`PH>^4_=3Y/:OQJQ<'QBZ^F,],NX(9Z+=?<N8
MI==HZB7<532OM_9;RQJ"8<;33U,3$@5S#WCOS'[S;WN9DAV939V)PIXRD#\1
M/X2?0==(O;'[D7(O+0MMQY]O'WW=%%?"[H;-&IBH!\2<"N:E00!4=4(;UWMN
MSL#<-?O/L?>&X][[JR4K2Y#=.]<_DMQYVJDED+D2Y;-5555E#(WIC#A`395`
MX]Q+=WEW>R)+?74DMPU?C8L?RKUF;M&P[3RYM]M8;%L]O8[6H.A(8EBC!\RN
MD`9\_P"?1[/C?_*J^>?RHI,?F^L.@MPXO9>2\<M-V!V9+!UML^IHG<*:_%U.
MY!3Y?/TRB[!L?152N!Z2>/8JV;VYYIYA*/:;:4MC_HLATKZX!H3ZXZAWG[[R
M'L][>R36N\<TV]WNL9HT%J&N)@?0E"(D/J&>OY=74=3_`/"7W=M93T59WK\K
ML/A)V\;UVWNI.OZG/:5*DR00[LWID\/$)03;6<.RBU])O[DS;/8:;M;=N8`O
MJ(DK_-N!_;]G6*V__P!X!!$98N3_`&\9DSIDN[@J*^1,42$_EXJ_:.C][0_X
M3:?`#!TT(W1N/Y"[]K$7]Z;)]BXK;U-.WUO]IM+:F&EB`^EA,?\`&Y]C"S]E
MN4K>IGDN)B13+:?\`ZAW<_OR>]-](S6D>TVJ_ATVQ=E'H&DD:OY@]"_3?\)^
M?Y8D$`A?J/?=2]C^_4]T]G-,&(L3>+<445_^0+?X>UX]GN1!_P`LV3_G(W^?
MH/G[YOO\6U#FFW`KP%I;_P"'17^?0;[I_P"$X?\`+MS<$PP3]];(JG#^*HP7
M:IRR1.XLA-+N_`;BCECB/(6XO^3[17'LIR5(@6WCGA8>8<G_``CHVLOON^^5
MLZFZO-MN8JY5[5!7[3&4/RX]$>[3_P"$O&'DCJZCI3Y99>GF\<AH\'VUUSC\
MI3R.JZH8ZG<^S<KAI88V;AG&*E91R%/T]AK<O8B.16;:>89$(&!(H(KZ$\3]
MM.I:Y>_O`MT1XX>:^0E:V_$]E.8C^4<T;J?]+KJ?7HB\?PG_`)V7\K2OK-V=
M%3[PW!L#%U;UM?\`Z"<\W:_766IJ0&>2JW'TIFZ1<PE*T;-Y95PJR#FTPL&`
M87EOW/Y$83;;(\MNO^^ZR1FAKWH315('Q::UH*9ZD^3W7^ZO]X=(K+G.Q@M.
M8)`(T-XOTLPJ*+IOHET`K7X6.D^8ZM1^#?\`PHGZO[+R>-ZO^:.UZ#H3?8EB
MQ/\`I3PSY&7JG)9I76FEAW;A\BD^X>JZN2?]9J9:W'1-J\L],H"^Q[RM[Q6V
MX7<6T\R6)L]P.-0!T5X"H.17U_P=8_\`N[]RSF#ERUDYE]M-S_?/+Y76("5%
MRJ9),+J1'=H!P9`K$4&DGK9:QF5QF;Q]!E\-D:'+XG*T5-DL7E,75P9#&Y+'
M5D23TE?05U))+2UE%502*\<L;LDBD%20?<U(Z2*K(X92*@@U!'J.L'9HIK>6
M2"XB:.=&*LK`JRL,%6!H00<$'@>I_NW3?7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]UF_L?\`(/\`Q'OW7NO_T=_)_P!1_P!A_O0]^Z]UC9@HN?R0H_Q)^@_US[]@
M`D\.O9\A7_-Z]:\G\U[^=WMKXIS9GH'XP3;=W_\`(^)9Z'=NZJGQYG8_2%3I
M1329&FB<4^Z^Q%CE+)C-?VF.=0U<6;_)'A[W"]T+;ESQ-IV9Q)O)7N;!6('S
M]&8^@^'SZS*^[M]U'<_<_P"FYMYV$MER$&#QJ.R>]0'+1@T,<`(TF3);\`\Q
MI0]G=I=D=U;[SW9_;>]MP]B=A;HJ?N<[NO<]>]?E*UAQ#31$A*;'8VD2R4]'
M2QP4E-&`D4:*+>\7-SW.^W2[FW#<+QYIF-26-<?T1P'KUU?Y9Y:Y>Y.V:TY>
MY7VF"RV6$4CCC`%*^;/\4KMYNY9CG/1RO@O_`"T?DW\^MP+_`*+-NIMGJW'U
MYH]U]X;SIZJDV#@VA*FKH,/H"UV]]R1HUA08X.L;D?<S4RD-[%'*7(F^\WS!
MK*%HMN#4::047_:BI+'_`(OJ*_>/[P?M[[-V,O[XO3<\R-&##81%3,Y/!I6!
M*P1_Z8ES^%2<=;I/PP_DS?"_X>TN%W!!LF#NGN"@BCEJ>V>VJ"BSM;3U[1*)
MIMH;1E67:NS*82`F$P035\8-GJY"+^\F^7/;;EWEL)(EJMSN%.Z66KFOF%4X
M4>F">&<=<KO='[S7NG[I27-O=;V^W<N2"@L[5FCC*"E!*]1)*<9#D+Z*.K94
M31?F_"@"U@JJ+!5`^BCW(``50H``'IC\ORZQZ%<U8D=<_>^M]>]^Z]U[W[KW
M7O?J]:J*5)QUP+&_I1F'Y-C:WYY_K[H2X--/7@RD5#"G71TM93_0-^+\_P"W
M(]^%3\0_U?GUY@&`[NPG\C_G_+JNSYD_RL_A[\VJ#)5O9_7-+M_LNHI98\=W
M+UW%1[6[(H:CF2&7(U]/328S>%.DI]5/F*:M0H2$,9(8!'F3D/EKFB-Q?V02
MZ-/U8^UQ3SJ./[.IF]LO?KW*]J+J$\N;\TFSJP+6=Q6:V88J`K5,>/.,K\ZC
M'5$>ULS\]?Y!^\Z#!=C#-_*+^6]F,XE(=Q[?HIY:OK*#)U>E*[&T53/5576F
MYH@P>3$3U,FV<RY9:6>"K<$17#+S3[5W20WK2WW);.`)%JQB!]>)%/GCK*_<
MK7VC^]UM;7O+\</+_OK%"2;<T6.^89(&G2KKZ2*!,O!D9:'K:>Z:[IZS^0'6
MVU>W.H=W8K>_7V\\>N1P&X,1,7CGC_144E932".KQF6QU0K05='4)'4TM0C1
MR(K`CW.VV;C8[M96^X;;.)+25=2L/\!]"/,'K`7F/EW>^4M\W'EWF/;9+3=[
M5RDD;@`U'XE-:,K<588(R"1GH5?:_HE\E/GU[W[KW7O?NO=>]^Z]U[W[KW6;
M^Q_R#_Q'OW7NO__2W\G_`%'_`&'^]#W[KW6NC_.\_FQ5'Q;V_5?%CX\9^./Y
M#[XPD=1O;>6.J(YJCI39.7IW2!Z)D8FF[)W532%L?J%\;17K"/(]->'O=#W`
M7E^V.R[5+_NZG0]X/]DO`D^C>G69_P!U+[NA]RMR3GGG""G(UG,!'&RDB\F4
MZM-,5A3`<@T)Q7B.M'=WEFEEFFEFJ)ZB:6HJ*BHEEJ*FIJ:B1IJBIJ:B9WGJ
M:FIG<O)([,\CL68DDGWBG*6FDUR-J=LLQXD^9)/775(88K>""&)5C0!0J@!4
MK@(@`[5_HCMKY=7U?RB/Y.6;^9U;0=^_(*BS.V/BSBJZ48#$P23XK</>V5QM
M48:NBQ-5$4J\1UQCZF%X:[)QE9J^9&IJ0J%FGCF'VY]M%YB*[MO&I-H5QI6G
M]K3T/\->/KUA=]Y?[T4/MJESR3R1+'-SX_;-)0/'8H0-+`\'N'#9C.(L')-.
MMZ#96R=H]=[4P6Q]B[8P>S=G;8QE-A]N[7VWC:7$8/"XND31!18['444--2P
M)R2%4%F)9KL23E+:VUO9V\5K:0K';H**JB@`]`!_Q?7)2^W#<-YOKO=MXNI+
MC=+AR\DDC%V=C^(L:DGY<!Y#I5?ZPL```!_@+>W^D_7O?NO=>]^Z]U'J:JGH
MZ>>IJ9X:>GIH9:FHGJ)8X((*>!#)///-*RQPPPQJ6=V(55!)('NK.%5F)[1Q
M/D/F?LZLJLSHBH6=C0`<2?(#U)/6O3\X/^%#/QQZ`K<SL+XW86/Y*]D8NHFQ
M]?N*FRSX+I7`5T+M'/&^\((*K([VJ*6:,HT>(A^T8\?>A@5]P_S3[P;/LD[V
M.U1_5WBL5)R(U(^8J7%?X<?/K,?VE^YGSWSQ!:;WSE>+L/+TH#*KKKNY$.=2
MPL5"(!DM(RD#\%,]5\[,[4_X4.?S%$CW!UM-5_''JG,.T^,W)3X;#=&[5?&5
MCL89<5F=QT.X^VMTTT,8TK4X^.1'M?4OL*07_O!SD!+9E+#;CP.G14>JLP+F
MOY?LZF+=-@^Y5[-%['>O%W_F**H=`QNM3#S8121P15_A8DCY]&>VW_)2_F3;
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M*RCJHG6IHJVFD1FBJ*:9-<;@I(BN"`/8)=OW?;VGC*3;?.I!&&5E-10^@/F#
M3K'F]M>8>3][:VN+>XL.9;&8<2T4L3KD$,*%?4$&AP17'5!60V#N;^1O\B(N
MQ=@-G]P_RN?D/O#'8KM?:M1/5YFJ^)?8^?JDQN#WOC'D::K;8=3++'!-.VIW
MI!]M4,]1!02316]K=^V>[I=V&I^2KQZ2H:GZ9C^)?1?D<?.M.LN%WBQ^]/RC
M^ZMY\.#WWV:T9[6:@`W>VB'="YQ2Z5`=(_%2H^)@-D;'Y&@RU#19/&5U+DL=
MD:6GKL?D**HCJZ.NHJN%*BDK*2IA9X:BEJ:>17CD1BKHP()!]S%'(LL:2(08
MV`92/-3D']G6&3I+%+-#-&4FC<JRD$%64T92#D$&H(/GU,]WZKU[W[KW7O?N
MO=>]^Z]UF_L?\@_\1[]U[K__T]S+YW_+3;/PG^,?9OR`W#'!D*W;&-CQFR=M
MS.T?][>Q,^W\.V;MS4MG%-596035;J=45#!-(.4]ASFG?8N7-DOMVF.8UH@\
MVD([1^WCY4ZD7VG]O=P]TN?=AY+V\,!<RUF<"OA0)0S2?:$^$>;$#KYF_8?8
M.\^V=^[R[0[%SM5N;?G8.Y,INW=V>K&+39/.9FH:IJY@OZ8*:$%8:>%0(Z>F
MBCB0!$4#!Z_W"XW6[N=QNVU7,S%B3D@GR!\A\N'7>GE_8-LY4V/:N6MEM5AV
MFQ@6&)%%`%7S/JS'+,<DDU/5BO\`*>_EYY'^8%\B5P>X_O\`&]"]6)C-U=TY
MVB)@J,C1U%3*<!UQB:SC[;+[ZGH9HY9EO)28V"IF4>01`C?VZY/;FS>T28$;
M5;=TS>M35$'S/G\JUS3J#?O*^]:^SG)&O;6C;G+<E>&Q0GX"`/%N)!QTQ`C1
M3BY`/GU]%+:VU]O;)VY@MH[2PV.V[M?;.'QV`V[@,/2Q46*PN%Q-)#08S%XV
MC@"PTU%14<"1QHH`"K[S'M[>&U@AMK>)4@C72JK@`?(=<2KJ[O-QO+S<=QN7
MFOKB5I)'<DLS,:EF)XDGCT_^WNF.O>_=>Z][]U[KH_0_[[G\>_4!P>'6C]O6
MH9_PH>^=/=U#V5M[X$=:TVY]I;-W1M3;NY]]9+"PUR9[NZHW=75E)A.O-MM2
M1"LK]J8R>A"5]/2,[Y/(2K32@1PF.;'OW=YHW:*ZCY4V])DMY0I9T!U2%N"*
M0*:1P:IZZ,?<K]HN3K[:-T]W^9[FSGNK.:2*%)&739")/$:ZE5CI!.%CU`BH
MJ,]'%_E1?R0NN?CYM[:7??RJVQB>P/D-DL=09S"[`W!0TN4V5T<TZK4TE+#B
MYQ-1;B[%I(6C%57U*/!CIPT5'&&0U,@CY"]L[39HH=QY@C%QNY4:5<`K".(`
M&06]3Y=1Q]XW[UF_>X=_?<J<D7CV?)$<C*\J$K-?%>WQ'84T1,14*M"PIK!J
M0-BU5"DD$\VM<DV`XL/Z#W+P5@U=?93AY#K"X"@`J3]N3^WC^WKE?_BON_6^
MO>_=>ZQR1)*K)(H='5D9&`9&5A9E93PRLO!!X(X/O1`92K`%#Q!X'K6=2L&(
M934$&AKZUZJS[!Z5E^".^-R?*3XY8M\?T+N?+1YWY>_'#"4K+MB#'3S(,[\F
MNFL'2C[?:_86RZ+_`"K<N)I(XZ#<>%AFE$<>0IXGF!4VV'E:YN-[VFHVM\W%
MN,HH/Q21#R8<=`P:GJ;-MYE_USMELN0^;)E_K+;QLNU[@Q"RZJEEL+J0U,T$
MK=L#OWPRL%KX;D"PG>^R>O\`O/K/<FQ-XXW#[XZS[-VG5X7-8^;PY##;CVKN
M7&E/)3SIY(98JJCJ%FIIXR2CZ)8V#!2!5=V]ON-I-;SH)+.9*,OD01Y?D:CY
M]13MFX[KRQOMINUA+):[[87`93E6CDC;@1Q&11E/'(/5='\M/.;TZ8K^Y/Y=
M?:^:K=P[J^(M9A:WI;>&7D+93LOXF;_-=-U)N"H=BXJ\IL6IH*O;&29&*Q2T
M$*V6XN$>4)KG;YMRY3O9"TMBRM$QXO!)4K3_`$A.DG/4P^\]KM?,,7+GN]R_
M"([/F!'%[$H`6WW6#2MTBTX)-59XZ@$JS=6O>QUU!/7O?NO=>]^Z]U[W[KW6
M;^Q_R#_Q'OW7NO_4-#_PI:^3E?O#OWJ_XHX:M==L=/;7I^R]Y4L;D1UO8>_Z
M:>FP$%6@:S-MW9$`FB!''\98_P!#[QD][M_:YW&TY>A?].W42.!_&PJM?]JP
MQUU(^XE[?Q[;RMS![D7*TW+<;@VEM7RMH*&>1#ZM,=!]?#(\CUK*L=",VEFL
M"0JJ69B!<*BKRS'Z`#D^X+C3454GC_EX4_,CK/XD5"EAG%3C[3Z5`!;/IUL&
M?*?YY?(W_A.A\$_BSUKT?\5<7NGMGY4[8R'<O<7R3[0Q6X\GU/LSLS<D:1XK
MJ6.BVY4X5LSOW:6T*2G"4E=E*."*F@,T4%49JGP9K>W7+R<N<L65N5I=3*))
M#YU85`/V#KA7]XOW*E]T?=/?=Z20G9[1S:V@\A#"Q753^*1JNQXFH'`#JOKX
M1_//_A4O_.$R'9>?^)?R*V]MW9O6E5CJ'=^:&T_CUU=L7!9C.4T]7B-KXNKR
MW7V=W5E\K445(\UH_NO!'I:>9/)'K'/4&]/U7_/Q_GN?R?OE3C.C?YHVWL/W
MIM]J;'[@RFTMU[>ZXP.9W-U[D*^KQJ[TZ=[@ZFPV)P^39ZC&5$<7\0@R4`J*
M>2GJ(:>74R>Z]UL+?S;?Y@/\PNK_`)??1_\`,O\`Y1G9O3^-^+474V8[C[UJ
MNQ=I;?S79\N`S%9M3&;8I,'@]W8G-;?6KV=D9LM29ZABE@KH:^GTH\JKH]^Z
M]U0]_*0_G*_\*&?YH7RGQO4G4O<OQXR^W^O(<!V3W-_I&ZEZVVEMR/JJ#>FW
M=O;AA2KVQM4;MK<K71YK13T^->&I8@MY8@I<>Z]UM;_SD?YV'Q]_E$=68NKW
M5C&[5^178N/KZCIWH/$Y>/$UV:I*.4TE3O7?&<6ER1V?U]CJT>$U!IYJO(5*
MM!1Q.8ZB6G]UXBO'K4KZD_F1_P#"G3^<3DZOL[X6=4];;`ZVVEN&LQ.(WYM/
MJ3I7`[1V?E'3748K;_;/R4&[]Q97/4-/)']\<'4O+`SH9HXM:`LM;6[O'(\"
M-(GPDJ"1]A.1^72B*[O((9[:WO)HK>44D1'9%<5K1U4@,*^3`C]IZ8.T_P";
MI_PIQ_D_[WV?5?/S;E)V/UKN3+R8[%'MK8'5F>ZZWH]#>>NQ6`[GZ$I\+4X?
M<\E`'EAIJRN-2L:^9J*6-#[=ITP34UZW-_Y2/\WOX[?S;^CJ_L7JB*JV)VEL
M*7'XKNOHS<>1I:[<_7F7R23MB\E0Y""*EAW1L7<8I)CC,M%##Y6AEAGB@J(G
MB&^M=6R>_=>Z+S\L.U.U>D?CEV]VOTAT?G/DGVSL;:%9F]B=&[;R]-@LSV-G
M8YZ:GAPU'E*FEKO`*>&=ZN5(H)ZJ>&G>*GBDG>-#[KW6D9_*>_X4+?S+/G=_
M.DZ8^.O>-7L3K#I#>D_=FU=U_'/:G7..QD.V<CLOJ_?NZ*%<CNG<T.4[,.[]
MO[DVC#%5&7(PP,RS1FDC#:5]U[K?PJZ:GK*>6FJZ>*JI9XWAJ:6>-)J>H@E0
MQS03PR*T<T,L;%61@5920>/>B`P9&`*D4/I0^O6U=HV61&*NI#`BH((R"",U
M!H1\P#Q'0,?'G961ZSZVI^M:JFJ*?#;`W!NC:^Q#4R+*S=:TF;K*GKVEC<2R
MN8,#M2LI<6I>SD4-R.;DLVBV-E:&RJ2D3LJD^:UJ./V]'?,>Z1;SNDF\I7Q[
MF*.26M*^.4'C''\4FIO]MT73Y&[;I-A?*?X>?)?'1/3U=1NC<GQ.[$J:>)A_
M$=A=Y8RIS>R/XD_Z?%@.ZMEX5*8D'0V8F`MY#[+-WMUM=YV/>5%&U-;R'U26
MA4'['`-?7'`GH8\GW_[RY)Y_Y)F(\,0Q[G;5_#<6ITS`>GB6LDE?4QK7AT?E
M;V]1N;_TM_3CV)AU&"DD9X]<O>^K=>]^Z]U[W[KW6;^Q_P`@_P#$>_=>Z__5
MMU_G#?R5^Z?E=WY7?*/XSY_9^3W)N[`;9PO8O6^^,W)M>:?*;2PU/MW#[CVE
MN*6DJ\1)'5[?H*2FJJ&L-*(Y:831S/Y61(+]QO;"_P"8]W_?FQL&NW51(C,`
M.U0H(KCX0//K/?[LOWK-A]M^5![><^V,_P"Y()9)+2>",2,GB.TLB.@(<@N[
M$,*T&"*"O14?@%_PGI[RI>Z-K=D?-4;(VOUOU]G<?N6#JW;FYZ?>>X.R,OAZ
MB.OQ./S>3P\7\"P.S4R$,4E8%J)ZVLB0P!(ED:4$7)_LWN$>ZV]_S,8ULH7U
M")34N1P!H=.D'C0Y_P``Z]YOOK\O7G+FY<O>U1N7W6]MWB:ZFA\%8$D&A_#1
MN\RZ20K8"G-?+H:?^%CT;K_*2VS:^D?+WJ!G"FRW.R>UT4L/R1^/Z>\DC2N!
M0=<S%`50!P_U?X>/1%/^$:W;'5O3/PE^:N[^X.RM@=5;2?Y+[*H(]S=D;QV]
MLC;[U_\`HKCJOL8\QN;(XS'R5II86D$2R&0HA:U@3[UU;JH[_A6!\[?C5\]/
MF#\;]B?$;>6"[RCZ1ZXW#LW<O8'7*2[APVZ-\=A[MQ];C=B;3S%!#)%O,8&#
M$Q,DN/-33-6922")VE20#W7NMBO<OQ;[1^&W_"1+LWH7NG'U6#[1P?Q4WENW
M=^UZXC[[9U?V=W#+V13;/R*!W$&7VWC=TP4M=$"1#6QS1B^FY]U[JC__`(1-
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M#_H*5H&-@/\`9IOGJQ^@`']S/D,2?Z!1_M@/?NO=;\N5_GQ?R>L)E<GA,G_,
M%^/D.2P^0J\77Q09_*5T$=;0SO354<-=0X>HH:R))HV`EADDB<"ZL1S[]U[J
MQ?9/>O3?8_4&'^0.R.S=E;@Z0S^U)=]8KM6FW!CX=BU.S:>":IJ]SR;BK)J7
M'4>%HH::5IYYWB2`1/Y"NDV]UXYK7JACY7?\*#?Y,&X<16]/P_.39\^Z\5OK
MK'=.'W7MWK;N3?.Q<?N'KOLG:F_*&JBWCL[8&8P=;2&7;WB-323SP@2$ZBM_
M:'<;/ZZV,((#ZT8$^11U8?X.CSES=EV7=/K959H&@FB=1Q*S0R1$?9W@_EU9
M/NW^;?\`RT-A=3]==Z;L^;/0.-ZD[>R6X,5UMO>+>M+E,;NO*[5CQTNZ<30T
M^(CK\G!E-KIEZ,9&GJ((9:)JN%9E1I4#+A0$T&/\OF>B/&*#IHZ9_G'?RO?D
M-V9M/IOI;YL=(]@]H;[KY,5LW96&SE?%F=R92.DJ*TXS%1Y'%T4%57RTU+(8
MX1)Y)2NE`S$#W[KW6/N+^<G_`"NOC[V7NWISN;YM=(;![/V%D?X/O/9>6SE?
M49?;67$$51)B<LN,Q==34V2IXIE\T!D,L+'2ZJP(]^Z]T,>WOYAGPQWELK8?
M8NQ^^]H;]V1V7B,IN'9VX]B1YK>%!D-O8/,YG;F:SU6-OXJOJ,/BL3G]NU]'
M/)6)`4J**H6W[$I3W7NC;_WFV_\`W9_OC_',1_=/^"_WC_O+_$:/^`_W<^Q_
MB7\>_B_G_A_\'_AO^4_=>3P^#]S5IY]^Z]U__];?PD4,W(O]/R?]OQ^??A@U
M''K1532HZZ``O;\_[8?ZW]/?NM]:IO\`PL<0-_*,PC?ZCY<]-$?[':':R\_T
MX/OW7NM??_A/)_)^^-?\W3^7]WYLOY#;K[;V4>G_`)>TNX]EY_J3<>%P^12?
M<O3>VL;G*#,8[=.W-V;>RE%5Q8^E>-S2)5T[PD1S*DLJ/[KW13_YLO\`*J[N
M_P"$Z?R1^.GRG^)O?V?W-LK<^?S[].]G9[;.V?\`2!UMV#MF@IY<IM'>F+GH
M*_9FY8<OM[+M-1UT=%31U<254;4D+0+)+[KW6R5N'^:15?S7O^$Q'SR[LWGA
M</MKN_KGK+/=1=YX7;R2P;>J]ZX7([%S5%O';='42SU&/P>]-NYNEK!2O)(*
M.M^YIT>2.%';W7NJ7?\`A%C235_S>^8-#3OXYZSX=5]+#)?3XY:CM78,,;W_
M`!H=P??NO=4-?RXJNGZ=_G&?$(=@QFG&R/GKUG@-S+6@_P"29*C[EH=NU3U6
MHC2:/*-J<G])0D_3W[KW7VJ3]3_KG_>_?NO=<'DCA1YII$BBA1I999&"1QQQ
MJ7DD=V(5415))/`'OW7NOB=_%B@K.T?YOGQ_@V2AK9MY?S%NM:S;S4MV#T^3
M^1V)R-)4Q,NK]J*C/EU?0(M_I[]U[KZ&?R#_`.%<'\MCX[]X]T=#;AZU^5^Z
M=S])=F;NZKS^;VGL'KN3;6:W'L;-5VW-RU&`J,[VKA,I)B:7.XV>&&6II*=Y
MT02*@5A[]U[I2?$3_A5G_+S^8OR5Z=^+^Q>L/E-M'>W=V\L?L/:&<WQLGKN'
M:M/N3+B5</39FHVYVCN'+TE-D*Q%@$T=',L;R*TFF,,Z^Z]UHV?#[YB=6_`G
M^?/VG\N.Y:?/UFP>H?D!\ZLM6X?;./\`XEN#<&:SN%[RVOM';&-A+1T]/4;C
MW7G**B:JG9::C2=IYB(XV]^Z]U=U_(F_E.=+?S?_`)"?(7^:W\JNI>FML_'O
M)]T[NQW6/PSZKCHL?UXV]D@Q]?6R;[P6%J8*C'[1VOC\I3R1X^:.DEW+EIY:
M^:*.A"PU?NO=*'_A7Y\RLST72_&O^51\=8,?T]T)0]08CM7LG8O7V-@VGM[,
M[?&X\MM+J7K>+'X7[.BI]D;7_N;D,A+C4B%-4U<M))("U,GOW7NH.X?AS_(P
M_EL_R7MD_P"SQ;8V;VI\\_E)\;J/M?`X[!9R;-_(W';_`.TME)NCK>/8E!29
M.E3J7KSKX9;'QU&2K8J?'U\E-4M,,A)*M(WNO=$5_P"$[?\`*"[>^?&ROE?1
M=^=/M0_##L?H?=>#ZI[3[%V_E*/^!_*RIJ,/!UEVST#/*:&OK<ALR@CKDS]?
M0%L774#+CZLS.8DB]U[I'_\`":O+]<?#S^=7+\;/F!U#LENU,AE^P.BM@;KW
MMA*>MW!TC\F-F9#*4>.DVID,BGAQ-1OFFHLI@(ZF*(3U%174/AD16;7[KW5G
MW\WGXN_'W^91_P`*._C+\%^F>K]A;:K\!B<5OOYY]I;+P]'B=Q[XB^PH^Q=X
MXW>V4Q4D,62SF&ZAV]BL915LJ_>+E-Q>.5W**J^Z]UM.;\_E:[0V]NOJW(_%
M["]5]4;&ZN7:-1LOK"3%9/![)Z_W-LC-8S+87<^-P6UJ2:EWSAZO^'!LAM[)
M&C2KR#RY!<C#5RF1/=>Z/I_LN^`_V5W_`&5_^\&6_@'^B#_1-_>CPTO\6\']
MV_X#_'/L+?PWR^3]_P"RM]II_8T^'T^_=>Z__]??R?\`4?\`8?[T/?NO=<??
MNO=:87_"S7Y5](83X7]7_#2IWCK^1&^.W^ON],7L"EQ>3J)*?JG:^,[,VM6[
MMS&76F&&QM+5[EJOM*2!YS55,D,K)%XXG<>Z]T7+_A%S\B>CMB=!?,?J;??;
MO76R>P*_N;9F_,/M+>&\<!MC-9K:TVQ!A*G-X2DSF0H),Q0T&2Q1BJ6IA)]L
MS1^72)8]7NO=`C_PL8_F*_&WO3`?'#X9]&=C[.[<W?UKV%G.Y>V\_L+.XG=6
MW=BU$FUJO9VT=DU&XL)65V,GW1DXL]D*ROHHY6DH(H*;S6:95'NO=)/X%?'G
M<GQF_P"$J7\RGL[N*2FV%5_,5,KO'J'`;JKJ?!Y3<VQ=O)L#9^V<QB\9E'I*
MRJFW=FH,E-0I$CM5T"TU1'JBFC9O=>Z!7_A%CN?;FW_G]\EJ#.;@P>&KMP_%
M:7&X"CRV7Q^,JLYD8^V>O9WH,-3UU3!-E*U(5+F*!9)`@+6T@GW[KW19O^%,
M7\L3L[X&?/C=?RWZPV]E<?\`&[Y*[]F[:V+OK;E++'C^M.[LA5IN'>^Q,K5T
M,"4^W<P^[4GSF$\AC2KH:@I`TDM)4A/=>ZW6OY2G_"@CX6_/;X_;!C[7[QZS
MZ*^5VW]LXO#]O]6=J;MP77PS6Z<51T]%D]Z=:Y3<];C,/NW:>Z:A#6Q04M1)
M78QI6IZF)=$<LWNO=%B_GO?\*%_BI\7/C%VKT/\`%7NS9'>/RX[=VAG^O,&.
MI-S8S>.W>E,9NC&/BL[V'N_>>WI\AMZBW)A<172G#XF*IEKY,DT,LT4=/&[M
M[KW6O5_PD?\`Y5>_.YOE%COYC79^UJ[$="?'4YVEZ<KLS0RP4W:/>.1Q55MX
M5N`CJ!'_`!';W6&*RM55U-=&#$N<:DAB9Y(:H0^Z]UO!=D_R6_Y5/;^_]X]I
M=E?!3H'=G8/8&X<ENS>FZ:_:TT.0W'N;-5#5F8SF16@KZ2EDR65K9'GJ95C5
MIYY'D>[NS'W7NG#J/^3_`/RN/CGV-M?N[J7X5=!];=C==5DV=VKOS';>>+(;
M4KTI*B"3,T%1D\A4T=#64E)-(4J2@>"^M&5@&'NO=?,2^&_Q?Z1^>'\\WL3X
MS=VYJ7&=5=Y=Z?-O%?WIPV?IL35X3-K@>[-Q=>;JP>2:ICQV0K,/O+&XZLIJ
M65I*7)-&*=TDCF*GW7NC<_`_Y5_)O_A,S_-'[#^-GR1BS.0^/^>W'B-L=\;;
MQD&1GV_O3KRLJ9#L#Y-=54%5H6KRV)Q%2U5$L=Y*FC:MQ4]JF-#3^Z]T;?\`
MX6'],CL/N/XC?S%^H<S1=F_'+O'H3$=3T?9&SZBFSNSZ/<FT\]N/?FU1+FL?
M-/#!_?G:._FJ*%)=#2?PRI%M2,H]U[H[O\E3X%_R1_EYMK#_`,POY"]YXGO/
MO.';&S(.TOCC\I>UMHTFT.@^P-B[9QNW,U5Y7:^X9\-D^P]BUW\"2IVW+F9:
MO`4F$>.D,,L],_A]U[K8A^,G\\'X$?)/YW?\-O\`Q1EW#V;D-I=<;AS\?;?6
MFV\1_LN>)78--2C([.P&:I*VDGJ<;C:&6."GR=#0-@I:HQTU-42:T8^Z]UJ`
M?\*T_AMN+X@?S`.E/YD?3%-6;<QO?>0P&>RVX<6C+3[6^3G2,F%J<=E=<4RF
MBJMV;5QF+R,*CQFHK,97R@EM9]^Z]U8#_P`)NJRBV;UI_,+_`)^GSQW-2X_<
MGR"[%SFT,)O2HQ.BJK\;'N.+<G8\?7^`I6D:H3>_9-?BMO8G'T_^9;;K0*RQ
M+(P*]XW>PV/;KK<]RF"6D*U)/G_14<2Q\@./[>A'RERCS!SUS#MO*O+%@]QO
M%W(%15X`<6=VX(B#+L<*N>K`Y?\`A4-UD-W2TT7Q'[';8HKGACSI[)VK'NI\
M:L^E,B=K_P`'?$I4O3#R?:_Q0@-Z/-_:]PL/?>Q^M"MLS_0F@#!JFA_%0T`X
M\.(ZS=_Y-_\`,_[I2X/N%9#>]()B$$A0,:#1XA;.337H`/D*=7E?\.%_&'_9
M+O\`9[?[XU_^@;^[?\<^[_A1_OA_%/XI_=_^Y']V/N?+_?G^\W^XW[+S:/N?
M5Y?!^][EK^MFR_N#^LOU/^ZVG&@K6M--.&JN*5_/K$[_`%FO</\`UR_]:/\`
M=(_KO]1X6BOZ?PZ_%U4IX6COU4^'RKCK_]#?R?\`4?\`8?[T/?NO=<??NO=5
MV?/G^5/\&/YE^&P&/^6_3%)O;/;0HZK'[+[#P6;S.S>Q]HT-;4)5U6.P^[-O
M5='5S8B>K3S-05JU="92S^'4Q)]U[K6P[U_X1Y?RNMD3XW<-9\U?D!T/MG=&
M[L#LK;=+V-NOI:NQV2WANVM-!M?9>`R^<V?M2?)[CW!7?L4%'KGJJJ3THKM[
M]U[HQWQ+_P"$U7\CSXU;EW]V%OOL^H^56<^,]=_$>X:+O7N'8!ZYZ7R%'A7W
M"DW;G7VQZ':N,P<%/A4;(&FW5-44;4T?E>)XU)]^Z]T;C^;'\4/Y(OSRR70F
MWOG3\NNK^GL[U)L*MS_4&'V_\K.I^F*JIZN[-@P=309JDVONB;(XS)[-RU/M
M2F?%Y"EHTB:&$K%,T0TCW7NJZ-N?R(?^$UOQYSW1G?>;^:"8K#Y++8SM'IW,
M]A?.+IW`[%[+@V/N6%ERNVLU1XG;$^Z<!C]QXX4]3/BL@NB:,Q^5&N/?NO=;
M(/>/R)_EJ=O?&T9#Y#]]_#[?/Q0[P?,[-H]P=E=J]49#I/LRLPE34IF<)A=R
MYC/_`-U\[F-O9'&RLXHZAJN@J:8N#')'<>Z]UK)]W?\`"9#^15WELG<?RCZ#
M^:&1Z)Z$QN0?^\F^.ON_NI>U/CGM6IJLA1T@H#O3>;9Q]N,,AEJ:!(*K<;B-
MZB)%4:T4^Z]T/7QH_P"$IO\`)QZ1[5VAA^T.SNQ/E'V5E=OS=C[4ZF[.[2V?
MM[#[GV=@*_&4M?O&FZ[ZWQ>V=S;LV;09/+44-3/)7U.+U54<4P;RJ#[KW6SS
MUUNSX\[4S%?\:NJ=R]28'/\`2FTMO293HG8F7VEC\QU5LBNI(WVO-D.NL'/#
M6[/VY6T3H:)Y:6"GEC=2A(8$^Z]T#.VOYD/\O3>>Y\#LK9_SG^(NZMX[JSU%
MM;;&T]N_(GJ7,[EW%N?)5D6.QVW,)@\?NVHR64SE?D)T@AI(8WGDF<(JEB![
M]U[J!\I<%\0?FM\1?DAU+VOW-M>3XYY2FW+U?WWOS9';N`VK3]=9+9>7QM7N
MO!Y_L&GR$^(V9GMIY:B@3*4>2.A`QIZR!HI7B?W7NM;;IS_A,M_PGS[PVAF.
MU^C/D]VEW%U]LB>>JW7O3K?Y:]3;PVKMC^#PRY2N&YL_M/8E1'MX4U!1R3R-
M-/32)`C2JRJNL>Z]U:W\^_Y:/\IG^:-L/XGY3OS?N)FHHTH^M/BWW+U=W=MC
M$[E[5QE;B*NLH^M-J[XR:[KH>W:>K@P-1DH::-*ZN2HIJJ>*1/)5^7W7NG#X
MP_RCOY5GPIZI[`_ERPUM)V9@/EQ)5]AYGH/Y*=K8'>F\]^T&R<?]M5[@Z_V5
M%!M:KQ]+M-$-3)E<)CXJVEJ8DG>J#01&+W7NJF=[?\)!?Y1^\>[<GM'9'R5^
M0O7NX:3"46^\K\?<!VMU/NC<N!V3DLG-BZ'.TU'NO8V8["Q^SZW)4TE)35]>
MU6KSQM&)WD4CW[KW6P?_`"]OY5?PG_EB;,S.U?BAU4-MYC=<=%%OGLW=63EW
M;VION/'/)+14^X]WUD4+QXFEGE:2/&T$%#C(Y6,B4ZN2Q]U[K5<_X5Q?./$]
MV;F^/'\G?H?'X7L#N3>/;G76_.S&IX!D<GLS=VX1-M3I?K;&NL4HQVY]U_WV
MDR61T$5$&->C3]%;(!L"I`Z]U&_G#5.R?B?T5\&_Y2_4&82JVU\3NJ,!N;MQ
ML<R1TV;[*S.'^WQ5=EX8UB_W,92HR&;W%,C`V.>A<C5I(QL][>8HI+BQY=6C
M"-?%D7T8X6M/0&OY]=,ON'>V\D%IS#[G[E;Z8YZVEL6'QHN;BGGI9BJ'UTD`
M\>J!W<(C2.VE$5G9C]%502Q/^``]X_T!0ZXZK0U`'[/YTZZ*A]66-0:#)H`*
M@5)]$7/V#\^MS?\`V0_L?_H':_T0_P`-R?\`I5_NE_LU']T/'']_]W_?/_2Q
M_=+QZ]7WW]RO3X_\[]Y^WIU<>\G/ZH77^L[^Z?$;ZWPOJ?AS75XE*5_A\_Y=
M<K/]>/8O^#0_K;XD7]6_J/W7X]3IT>#])]16G#Q.[_2^?7__T=_)_P!1_P!A
M_O0]^Z]UQ]^Z]U[W[KW5'/\`/DI9ZOHKX0+34T]4\'\V/^7I4RK3P23M#3Q=
MQ7FJ)!$CF.&)"=3M95!Y/OW7NM<OYK[`[ZZ7W[_/^^;_`$MCMW;ZV3NKN;MG
MX5?+SI6BIYIJ/,]&]L?$3K"/JOOO:U**>3_?R=!=Q[LDGR$EF6?;V7K%\D,<
M<S-[KW5H_P#,FZ5ZUW!_+\_DD;GRO4FQMQ;TK/E]_*$V1N;<>2Z^P&8W-7=?
MR8FE3,[2SF6J\/492IV;-$\BU6/J9#0LKLLD=F(.P"QH!GK8!(JH)%/+H-/Y
MS%/U'TC_`#-O@72U/9?Q=^(G5>!^%GR5P>*W-WC\4,=\A.C,+5U_:?7E;2;3
MQG4&*K-L8;$[@S4JU$]+71RQ_;K'4#0QG-]=:ZA?*['4WR.ZW_D483XO]G_#
M_N_(9OYF=^XC%=H4_P`3JS`?$3/[IQ?3O;ISE3FOC)CMPXJ:BQ=-5T\E++"F
M60OEHQ7"5CZ/?NO=$NW)L-\'_*H_G\[0[KVMA^M/F]N#OCXYX[Y4?&WJ3KFB
MZQZ)V;MS"]J=1[4ZF[!^-&U,-49A\MUUV_L5)\O+GI9/O:S)"0U4$9C22H\#
M7AU[HZ/PSK>X/B'_`#>=O_&?Y6_WBKNN/Y=W\M7Y<P=0?)C/K55U'VW\,,IV
MQT/OKJ?+YRN%.%DWQU!M7;>0VIF@E_N),)'(H9F9W]U[HD/Q1[(^6'2/R\^.
MW\Y'O'XC]P=7]9_-_P"0O8^V/E+\@,]V#USFM@;E^+GS!KMD;7^'.$'5F(W+
M7]E['V[\?VV3MN<5V5QR>6FJIUE8>6`#W7NKU>AOC?T/AOY^/S!@QG0?46*P
MNTO@K\/MX;+CQ_5&RZ#%[;WPW;';DE3NK;'V^`BI<-NMC24YDK:0QU9\,1+G
MQII]\O/KW#)X=4L9S:&1J?AWOO=G8^P-W[\^''67_"F_Y'=I?.?9.#VOF]S0
MY3XX8G?E23NK>>R\315.6WIU9MC>M3B\AF:6*"IBEIXEE>-TC)7=#PIGK84D
M@`&O1O*'=7QL^0GS[^67?7\L?;V&JOBQA?Y0/R'ZY^6/:G3>Q:W8O0G8/=U6
M]7DNE=FPTR8+;NW]Y]J[2VE3UTTU30TU1-1XV9::68$&+WKK75:_PVV1\@?C
M7DO^$]?QRS^*W5OOXO=_=_\`QT^=O0_8>2@K9WZ5["SWQQ[`P/R;^-N9D:)D
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M3I(BS1(UB-2CD>_=>X<>M/3)_P`D[I/^55\G=[_SF/E_\V-X_+3?VT-Y[X[+
MZWZYW;UEB-HYGLCY&;ZI<W#L./*9Z+?FXOXO6X/(9!JJGAHL?0TU`*)*L>&F
MHO"Q#S+O]GRUL]SNEVX!4=BGB[^0'KFA/RZ'WME[>[U[H<Y;3RAL43&:9@TK
MT.F"`']6=S2FE%KCB6HHR1UKH=M]J;W[R[0W[W)V7E/XSO[LS<^3W?NK(J-$
M$F3RDNO[6AAN12XK%TRQTM'"OIAI88T'"^\'MTW*YW:]N=PO)==S*Y8M]OX?
ML'#\NN\_*G+&T<E<N[5RKLD&C:+*)8XU/&BBA8GS9VJ['S9CT>7^5'\)\A\X
M?E[LC9&4QE7/U!U[44?9'=F32.1:)=IX6L2;%[0>K5=$60W_`)N*.@1+B3[+
M[J9?\R3[%7MYRS+S/S%;0,/]UT#*\OH0/+]M,=0[]Y?W8C]J?;3=;BWD5>9=
MP5K:R0GN!D6DLP'HBDU^9`\^OI%?:Q?8_9^"#[;[?[;[7PQ_:_;^/Q_;^#3X
MOM_%Z-%M.GCZ>\U-,>GPM`\*E*4Q3A2GI3KAUJFTZ_$/U%=5<_%QK^W/7__2
MW\G_`%'_`&'^]#W[KW7'W[KW7O?NO=8Y(HI0!+%%*%9742QI(%=#='4."`ZG
MZ'ZCW[KW77@@M*O@ATU&H3KXH[3ZD$;>8:;2ZD%CJO<<>_=>Z(Q_,!JOEUMG
MH.N[#^%L^WJ[M/J[+4&]\GUEN/:>.W-1]O;'P^N7<NPL29PE=A=R2X\&HH)J
M)XZB:2$TZ$/+&0&.;&WZ#;&O.7FK?0G5X=*^(OFOK7TIU(GM/;^W]_S?;[1[
MEQ31\OWL1B%S'(1]),V(YF531T5OC!!P:^74WX-_-SI7Y\]+8GM;KJ2DIL[0
MB'$=D=:YC[>?=_5N\%C)K]O9ZEDC2=J&>6)Y<?7!$AKJ:S`+*LL4=^5^9['F
MK;([^T[9A59(S\<;@T((XTKP-/Y]6]T_:[F+VEYHDY=WR/7:/W6MTH+0W4)&
MI)(W&/A(#+4E6P?*H_=T]?[TW]UKG]L=6]I9+HO?E1##/M;LC`;5VINV;;>3
MIYTG#3[8W9C:_#9;&5Z*8:N']B=X9&\<T3@,#?<;>ZN[&:"QOS;7+?#(`&H1
M\C@CR/01Y?W#:MIWFTW#>]CCW+:D)\6V>1X@Z_*2,AT8<017-*@C'5/^=^</
M\Q3X6//C?FI\+#\G.OJ%1"/D_P##>G?)?Q'%4TKL,COCJ/*TTN0VU7K&4+Q^
M:CH5<'QNX]1`$_,W-O+9,?,'+YO+4'%Q;>8_I1Y(/G^$'R&.LC-M]K_97W/0
M3^W/N8NQ[T]/]UN\#2H8CX(;Q:*ZUX:UU4X]<\7_`,*)/Y:F2BT[FS'<.QLF
M(O#/@]Y=+YV3)0I(!YJ63^`5&X*4QEA9AY-)(^GMJ+W?Y.((N9+B%QQ#1T(^
MVA/2VX^Y9[YJU;#;=NO+:E?%@O(FBIY=S:>/$4KTC>P/^%)?\N[;F-GCVIB>
MZNS:L1`4N-QG7>/VSC)F0:HHIJW>^X,)]M$K(.5II2/J%/T]HKKWKY/A1C;"
MXF(]$IGR'1MLOW&O>W<YM-\FUV5J#W.]R)"!YE5B5ZT]"5ZK1[%_G6_S(_FQ
MN!=C_`3XW[BZWIJBHA4YS9FTI.W.PJFD9U$"YC>.<V]3]<;/QJR*3([T]D4L
M#4@7/L$W7N7SOS1<+:\I;-+%$>+*A=OEK+`*J^I%:8P>ILVC[K7L1[66[;Q[
MQ^X,%]<HM#$6^GB4TKB))/JIB:4`6BGC0'JY3X"?''^:G%D\%V=\\?F-E%QU
M))#6TOQSV/MOJJL&4-B3%V?OS%[)IX%BNP\M!A)'9R/57VO'[DOE+:>>E:*]
MYKW\DC(@0+3_`&[@9^P>?6,/O'SE[`RPW.Q>SOMJL8P#N$LEPK$UR8(&E("_
MTI*D_P`(ZN@IJ&BHJ?[2CHZ6DI07(I::F@IZ<&0DR'P0HD5W)-^.;\^Y)^SA
MUC5^?63[:GTQ)]O!H@8/`GACTPN%*AX5TVB8*Q`*V-C[]U[KM(((XO!'!#'#
M9AX4BC2*SZM8\:J$L^HWXYN;^_=>ZQ-04+A-=#1N(T6*/72P,$C3],:7C.E%
M!X`X'OW7N@:^07R$ZA^+'5.Y.XNZ-VXO9&PMJTGDFJ:DK][E*YP1CMN[9Q,9
M6HSFX\O,/%245.IDE<W.E`SJ6;OO&W[%8S;CN5RL=NGKQ8^@%<D^70FY0Y/Y
MDY\W^PY9Y4VQ[O>+AJ*JCM5>#.[4HB(,L6H/*M>OGC_S(/YB79G\PSN<[QW!
M!5;2ZEV9+D,=TUU8*OS0;8P]4\:U6X-P-`WVN4WYN2.!'K:D!DIX]-+`?%'J
MDPYYWYTGYPW1Y&5TVZ('PDS09^(^I(Z[4^P7L7LGLKRL+*&2*ZYJNT#WMSHH
M0ZG$$3$5$:@Y`^(C4>B7]5=5]A=X=C;/ZCZHVQ7[R[$WYF:?!;7V[CD/EJZV
M<EYJFKJ"##CL1C*97J:VLE*P4E+&\LA"J?88VK;+O>=PMMML8B]U*P`IY5-*
MGY#SZECF?FC8>2]@W/FCF;<$MMDLXB\C$5:G`!%J-;EB`J"K,3CKZ.'\MGX$
M[)_E^_'G%]8X>:DW#V)N22EW3W'V!#3^%]X;WDI1`T%`)+S0;5VM3'[+%0,0
M5@5YG'FJ)B<T.2^4X.4=H2P0!KHFLCTRS?\`0(X#^?7#?WM]WMZ]Y>=;CF'<
M-46UPKX=I!6JPPUK3T,CGOD;U.GX0.K#?['_`"#_`,1[&'40=?_3W\G_`%'_
M`&'^]#W[KW7'W[KW7O?NO=>]^Z]U[W[KW71XYM?Z'@<\'C_;>ZDL*4Z]UKG_
M`#\_EW_('H;NW)?S&OY85?/MSN0>?*=Y]!XRG63;G;V.#?=YS*8C;*S4M!GZ
MW+I"9<G@V*2UE3_EF.DAR-Q-#_-O*6[[5?2\W\E7)BOU[IH:=LH)R0.%?44S
MQ'68GL_[Q<G\V<L6OLI[]Q>-RP=26.X$_J63M\*%S_9H6I^K7L7M<-&30Q?P
M#_G7_&_Y@?P7KKL2II/CU\C7:3%9+K3?%>]'M_<.=H7>"NAV#NW)PT-+65;S
MPM;#Y#[3,P/>+Q3E#(QWRG[D;)S"HM+@_1[RIHT4E14CXF!.,FN#^T]`_P!W
M?NQ\\^VCR[QM!7>^1F&N.[M^Z1(S0J9H5U%5HP'B*2A'=45IU=&K+?TFS'_`
M@_UL>+CW(U?GC^6?3K&LG4*U'&GY^GV_+H,=Z]']+]D2/-V%U%UAOJ=[:I]X
M[!VIN69K?UFS.)K9;V)'U_/LNN=FVF\_W*VV"3_31H?YD5Z/-MYGYEV84V?F
M&^M5](9Y8Q^Q&'2#P?Q`^*.VZI:[`?&;X_X2L#^1:O&=/=>TM4CC^TDT6WQ)
M&QM]00?:=.6^7XW5TV:V##_A:T_92G\NC"YY^Y[O8S%>\Z;K-'Z/=3L/YOG\
M^C`8_&X[$T<./Q5!18R@IUT04./I*>BHX$L!HAIJ:.*&-+*!95`M[.(T2)%C
MC4*@X```?L%!T%YII;F5I[B5I)CQ9B6)_,DG^?4WW;IOKWOW7NO?Z_'^O[]U
M[KB74<7N?K8`D_[8`GWX=P)7K1(&JIX"O^KY_+CU4'\\_P"<Y\4_A739C:F-
MS=)WEWO2Q/!2]2]?Y:GGI\)7_H7_`$B[TIXJ_"[-@IWYEI3]SE6`LE)8ZA'O
M-'N/L/+44T9F6XW):?IHP-*X[F%0/F./617M#]V3W&]VI8+V.S_=O*5>^[N%
M*ZEQ7P(^UY&]."?TQ3K2%^9?SC^07SJ[*;L/O/<ZU-)C9*N/8W7F!^ZHNO\`
MKK%U+@M0;9PTLTS2UT\:**K)5;39"L*@/($"1IBQS-S;O'-EW]3N,I$"_!&#
MVJ*FF/7/76GVJ]F>1_9W9UVSE>T+WLB`3W<M/%F;S+/Q"UX1@A0/*N2$G0GQ
M^[C^3_9N#Z@Z*V-E=_;]SSJT>/QZ>+'X;&B14JMP[IS,VG';:VWCPVJ>MJWC
MB'Z$UR,J,6[-LNX[]>QV.V6S22L:$CX5'F6/``#/0GYZYZY7]O-@EY@YSW5;
M;:X>Y<_J2,.$<*\9)&X!17YT%3UOR_RO_P"5/UK_`"]]G5&=R-90]B_(O>>.
M@I]^]G_9>*AP]"RQSR;&ZZIZM#5XC:5/5+JGJ'TUF6F199PB+#3PY><C<A[;
MR?;&1:3;K*.^4BE/DOH*8ZXU>_?WA.9/>S>$B(:RY.M96:WM%;#'@)I\T,K`
M"JKVIP%14FVU1I`']!;V/^L>@*``=9_['_(/_$>_=;Z__]3?R?\`4?\`8?[T
M/?NO=<??NO=>]^Z]U[W[KW7O?NO=>]^Z]UQ(O;_`@_[;Z?T_/OWS\^O=4O\`
M\Q7^2M\>_G`<SV)M)Z?H_P"154C57^DC`8J.HV[O.M@1#2Q=E[1@EI(,O,7C
M"C+T;4^6B%B\E0J+%[C?G#VSV3F@M?0@6V]`8D6H#<<.!ZGB1GK)CV7^]%SW
M[2I'L=S*VZ\EUI]+*Q+P@X/TTA!,8()U1MJC?A0<>J&YOD'_`#FOY-&0I-H]
ML4E;VY\?L76"@P.4WPF3[1ZBK\<I"P4VV>TZ)Z??'7LKP@&+'Y2>G2$WT4C@
M%O<3/N_N7[<SQV=\WU.TJ,.07C*CA1@"RGU!H>LMX^2?NN?><MVO^5KF+9N>
M'`+QQF.UG#'XM5LU8;@5_'$0S>9'5E'1'_"F3XS;MIZ"A[_Z>[,Z<RTD%.M3
MG-IO0=J;+:J=@)IE:C.#W9246F[@G'SL!Q=CS[&NT^]_+]VJC<[26W8<6%&7
M]AH0/VGJ%^;ON(>XVV&2;E'?;'<[770+*?I)J^@634C9\]0K\NK1>O/YMW\M
M[LT1+MWY?=14-1*55:3>V4K^MZM9&O\`M-#O_';<U./SI+#_`!]CRTY_Y-OM
M+6^_0Y\B2/\`"/\`+U`&]?=U][^7S(-S]MMSTJ<M%%XR_D83)CY]&DQ'R@^-
M6?@CJL%\ANC,S3R@&.?%]M;"KHW!%QI:GST@^GX]GB;YLTBADW6W*G_AB_Y^
M@!/R-SM;,R7')^Z(P-#6UG'_`#YU[-?*'XU;=II:S/\`R&Z-PE)``9JC+=L[
M"H(HP?TW>HSZ`%OQ[TV^[*@9FW:V`'_#$_S]4@Y*YRNI4@MN4]RDF8X5;:8D
M_D$Z*;V'_-^_EL=:+.F=^7/5N5JX0]J+8E3F.R*J61"5\4?]Q,5GZ82,PL-<
MB+?\^R.^]P.3]O4M<;[!CR4U/Y4%.I&V/[N'OCO\D:V7MQN*1OP:=!;J*^9:
M8I2GV'JKSO'_`(4T?'7;4==COC_T?V7VSE%@D6ASV]ZC&]8;0-6I=5>2!O[Q
M[LJJ7@,+45.S`_53[`.[>]VRP*PV;;YKD\`S=BU^8^+^74]\H_<2]P-S$5QS
M=S#9;9;@]R)6XE(]%*Z8Z_:W5!/RN_G-_.[Y80Y?;V5[)3IOK7+>2"7KGI-*
MO:5-5X][@T6>WBU14[WS\4J'1-&U;3TDR_6G'N)-_P#=#FK?@\`NA;6;?@A!
M4_FY[CUF5[;?=.]HO;Z6"_;:&W;>U^&:\HP5J_$L2_I@CRJI/SZJVQ.+R>>R
M]#@<#C,GGMP9JK%/C<+A*"MS&;S%?4R`>*BQF/AJ<CD:RHE?D)&[NQN;DW]@
M!8Y[MWAAA>2<D8"ZC6N">)R>/61]Y=V&TVTD^Y745KML0+&5F2&.@'`UH``!
M_#0`5IU?E\)O^$^OR>[^EQ>\?DG45/QBZMG>FJCA<A24V3[HW)0R)YO#0;6>
M5L=LE9ELIGS+_=PEB?L6T\R]RQ[.[UNZPS[ZPL[($'3QD>M#PR`OVY^76%7N
MS]];DGE);C:_;W1O>_9`D-19PL#QUG,[#B-`T''=UN*_%3X<?'GX8=>Q]=?'
M_K^@VEC)S#4[@SM0QRF\]YY..,(<MO+=-4#DLY6GDHA*4M."5@BB3TC(_9.7
M-GY=M39[59K'&:5-,L1YD]<SO<#W)YU]S]ZDW[G3?9;N[).E*D11`_ABC^%!
M]@J?,GHT7L\Z`@``H!CKWOW6^LW]C_D'_B/?NO=?_]7?T9222!_O7]/?NO=<
M=#?T_P!Y'_%??NO=>T-_3_>1_P`5]^Z]U[0W]/\`>1_Q7W[KW7M#?T_WD?\`
M%??NO=>T-_3_`'D?\5]^Z]U[0W]/]Y'_`!7W[KW7M#?T_P!Z]^Z]U`R6(QV8
MH*W%Y;'4.3QN2IY:3(8[(TE-74%=2S*4EIJVBJDEIJNGD5B&2165@;$>Z21Q
MS(T4R!XCQ5A4'\CCIR*66WDCFMY&CF0U5E.E@?4$4(/Y]5!_(K^13_+Y^0-1
MD,S0]85O1>[*\U4S[AZ+RD>S:*2LJ!<559LJHI,KL:HT/SICQ\!-SZK\^X]W
MSVMY1WO7(;'P+EOQ1L5H?73P_+'61W(_WL?>CDA([4<PC=-L50!%?+X]`,46
M34LHQ@'4>J7NX/\`A,!W#C9*NIZ)^3'7^]*$,[T>$[8VGFMEY18[^BG?.[5D
MW?C*J8#ZO]C2H3^![B[</8O<HV9MKWN.2,_AE!6GH:J#D^?64_*GW^]A,0BY
MM]O9[>8\7LY5D0GSU1RZ#3Y!R?MZ(!O+_A/[_,OVO.T=%TEL'?D&LJ*S9G:N
MP9(F46LXI]VUFTL@O^QA]A>]]H>=K4)X5K%.3_ON6@'Y.5ZFC:OOF^Q.Y"-K
MGF*ZLY*?!+9SJ$^0,/BJ?MQT'H_D>?S-T/I^)E:I!^J;^Z=6Y%^05WR"1[*G
M]K^?&[6V"0@?\-B_ZV="%OO:>PC`U]PT*GR^FO"/V>!TY4G\CK^:+5R)!'\7
M:BFUNL9>M[.Z@I8(U8C]QW.^7LJ6YL"?\/>D]JN>'8)^XVB)_$7C(_/2Y-.D
MLOWMON_P@L>>%=//3:7;,?E1H@M/3HR_77_"<+^8+NV:G.],IT3U/0OH:HDS
M>^\IN[)TZDC6J8W9FW,E0U$JCZ+]^BD\:A]?8CL_93FV66-KV:VC%<D2,:?.
M@&>H^WO[\_M!MHE.S[7NFX2K\.F)858_-I64A?4>"2?(CJT7HS_A,=TAMV2E
MR/R)[\[`[4J$!>?;/7>+H.K=M.Y06@GRM14[KW75Q!_[4-10L1^!['^T^QNS
MV\@EW?=);D?P*HC7]M23_+K'WF_[^?.NXI+;\G<IV.W(Q_M9F:YDI\DHD:G\
MF%>KT_CE\'?BK\3:)*?H+HS8/7]?]M]K5[HH<0N2WQDHRBK*N3WMFY,ENBK2
M=EU/&:KPEOH@%A[E3:.5^7]A31M.U11<,Z06-.%6-3UB'SC[G>X/N%+XO.?-
M5U>J&)6,NRPIFH"0@B-:>5!^?1JO%;^P.>?Q]>?^*^S\DG)/0%`````H/]6/
M3KEH;^G^\CWKK?7M#?T_WD?\5]^Z]U[0W]/]Y'_%??NO=9;>FWYTV_WCW[KW
M7__6W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]UT54_4`^]$5Z]UUI7_4C_`&P]^H.O8].N](_H/]M[]0>G7NN_?@`.
C'7NO>]]>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z__]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
